Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

Abbreviations: A1C = hemoglobin A1C; AACE = American Association of Clinical Endocrinologists; ABCD = adiposity-based chronic disease; ACCORD = Action to Control Cardiovascular Risk in Diabetes; ACCORD BP = Action to Control Cardiovascular Risk in Diabetes Blood Pressure; ACE = American College of E...

Full description

Saved in:
Bibliographic Details
Published inEndocrine practice Vol. 26; no. 1; pp. 107 - 139
Main Authors Garber, Alan J., Handelsman, Yehuda, Grunberger, George, Einhorn, Daniel, Abrahamson, Martin J., Barzilay, Joshua I., Blonde, Lawrence, Bush, Michael A., DeFronzo, Ralph A., Garber, Jeffrey R., Garvey, W.Timothy, Hirsch, Irl B., Jellinger, Paul S., McGill, Janet B., Mechanick, Jeffrey I., Perreault, Leigh, Rosenblit, Paul D., Samson, Susan, Umpierrez, Guillermo E.
Format Journal Article
LanguageEnglish
Published United States Elsevier Limited 01.01.2020
Subjects
Algorithms
Blood Glucose
Blood Glucose Self-Monitoring
Carbohydrates
Chronic illnesses
Clinical medicine
Consensus
Counseling
Diabetes
Diabetes Mellitus, Type 2
Diabetic ketoacidosis
Endocrinologists
Endocrinology
Ethnicity
Fatty acids
FDA approval
Food
Glucose
Humans
Hypoglycemia
Insulin resistance
Intervention
Lifestyles
Lipids
Meals
Metabolism
Nutrition
Obesity
Patients
Prevention
Proprotein Convertase 9
United States
Weight control
United States
Online AccessGet full text
ISSN1530-891X
1934-2403
1934-2403
DOI10.4158/CS-2019-0472

Cover

Abstract Abbreviations: A1C = hemoglobin A1C; AACE = American Association of Clinical Endocrinologists; ABCD = adiposity-based chronic disease; ACCORD = Action to Control Cardiovascular Risk in Diabetes; ACCORD BP = Action to Control Cardiovascular Risk in Diabetes Blood Pressure; ACE = American College of Endocrinology; ACEI = angiotensin-converting enzyme inhibitor; AGI = alpha-glucosidase inhibitor; apo B = apolipoprotein B; ARB = angiotensin II receptor blocker; ASCVD = atherosclerotic cardiovascular disease; BAS = bile acid sequestrant; BMI = body mass index; BP = blood pressure; CCB = calcium channel blocker; CGM = continuous glucose monitoring; CHD = coronary heart disease; CKD = chronic kidney disease; DKA = diabetic ketoacidosis; DPP4 = dipeptidyl peptidase 4; eGFR = estimated glomerular filtration rate; EPA = eicosapentaenoic acid; ER = extended release; FDA = Food and Drug Administration; GLP1 = glucagon-like peptide 1; HDL-C = high-density-lipoprotein cholesterol; HeFH = heterozygous familial hypercholesterolemia; LDL-C = low-density-lipoprotein cholesterol; LDL-P = low-density-lipoprotein particle; Look AHEAD = Look Action for Health in Diabetes; NPH = neutral protamine Hagedorn; OSA = obstructive sleep apnea; PCSK9 = proprotein convertase subtilisin-kexin type 9 serine protease; RCT = randomized controlled trial; SU = sulfonylurea; SGLT2 = sodium-glucose cotransporter 2; SMBG = self-monitoring of blood glucose; T2D = type 2 diabetes; TZD = thiazolidinedione
AbstractList Abbreviations: A1C = hemoglobin A1C; AACE = American Association of Clinical Endocrinologists; ABCD = adiposity-based chronic disease; ACCORD = Action to Control Cardiovascular Risk in Diabetes; ACCORD BP = Action to Control Cardiovascular Risk in Diabetes Blood Pressure; ACE = American College of Endocrinology; ACEI = angiotensin-converting enzyme inhibitor; AGI = alpha-glucosidase inhibitor; apo B = apolipoprotein B; ARB = angiotensin II receptor blocker; ASCVD = atherosclerotic cardiovascular disease; BAS = bile acid sequestrant; BMI = body mass index; BP = blood pressure; CCB = calcium channel blocker; CGM = continuous glucose monitoring; CHD = coronary heart disease; CKD = chronic kidney disease; DKA = diabetic ketoacidosis; DPP4 = dipeptidyl peptidase 4; eGFR = estimated glomerular filtration rate; EPA = eicosapentaenoic acid; ER = extended release; FDA = Food and Drug Administration; GLP1 = glucagon-like peptide 1; HDL-C = high-density-lipoprotein cholesterol; HeFH = heterozygous familial hypercholesterolemia; LDL-C = low-density-lipoprotein cholesterol; LDL-P = low-density-lipoprotein particle; Look AHEAD = Look Action for Health in Diabetes; NPH = neutral protamine Hagedorn; OSA = obstructive sleep apnea; PCSK9 = proprotein convertase subtilisin-kexin type 9 serine protease; RCT = randomized controlled trial; SU = sulfonylurea; SGLT2 = sodium-glucose cotransporter 2; SMBG = self-monitoring of blood glucose; T2D = type 2 diabetes; TZD = thiazolidinedione
Author Umpierrez, Guillermo E.
Grunberger, George
Rosenblit, Paul D.
Mechanick, Jeffrey I.
Abrahamson, Martin J.
Garber, Jeffrey R.
Einhorn, Daniel
Garvey, W.Timothy
Bush, Michael A.
Hirsch, Irl B.
Jellinger, Paul S.
McGill, Janet B.
Handelsman, Yehuda
Blonde, Lawrence
Perreault, Leigh
DeFronzo, Ralph A.
Barzilay, Joshua I.
Samson, Susan
Garber, Alan J.
Author_xml – sequence: 1
  givenname: Alan J.
  surname: Garber
  fullname: Garber, Alan J.
– sequence: 2
  givenname: Yehuda
  surname: Handelsman
  fullname: Handelsman, Yehuda
– sequence: 3
  givenname: George
  surname: Grunberger
  fullname: Grunberger, George
– sequence: 4
  givenname: Daniel
  surname: Einhorn
  fullname: Einhorn, Daniel
– sequence: 5
  givenname: Martin J.
  surname: Abrahamson
  fullname: Abrahamson, Martin J.
– sequence: 6
  givenname: Joshua I.
  surname: Barzilay
  fullname: Barzilay, Joshua I.
– sequence: 7
  givenname: Lawrence
  surname: Blonde
  fullname: Blonde, Lawrence
– sequence: 8
  givenname: Michael A.
  surname: Bush
  fullname: Bush, Michael A.
– sequence: 9
  givenname: Ralph A.
  surname: DeFronzo
  fullname: DeFronzo, Ralph A.
– sequence: 10
  givenname: Jeffrey R.
  surname: Garber
  fullname: Garber, Jeffrey R.
– sequence: 11
  givenname: W.Timothy
  surname: Garvey
  fullname: Garvey, W.Timothy
– sequence: 12
  givenname: Irl B.
  surname: Hirsch
  fullname: Hirsch, Irl B.
– sequence: 13
  givenname: Paul S.
  surname: Jellinger
  fullname: Jellinger, Paul S.
– sequence: 14
  givenname: Janet B.
  surname: McGill
  fullname: McGill, Janet B.
– sequence: 15
  givenname: Jeffrey I.
  surname: Mechanick
  fullname: Mechanick, Jeffrey I.
– sequence: 16
  givenname: Leigh
  surname: Perreault
  fullname: Perreault, Leigh
– sequence: 17
  givenname: Paul D.
  surname: Rosenblit
  fullname: Rosenblit, Paul D.
– sequence: 18
  givenname: Susan
  surname: Samson
  fullname: Samson, Susan
– sequence: 19
  givenname: Guillermo E.
  surname: Umpierrez
  fullname: Umpierrez, Guillermo E.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32022600$$D View this record in MEDLINE/PubMed
BookMark eNptkctu1DAUhiNURC-wY40ssWHRwLFzc5ajMAWkIhZTJHaR45zMuHLswXaA7HgHHor34ElwmHIrrGxZ33-x_tPkyFiDSfKQwtOcFvxZs0kZ0DqFvGJ3khNaZ3nKcsiO4r3IIOU1fXecnHp_DcCgpvxecpwxYKwEOEm-NtZ4NH7yZBNEwBFNIN1Mwg7JakSnpDBk5b2VSgRlDbEDabQy8V2TtemtdMpYbbfKB0-E6X-rGqs1bnFR_AnOJLos9o0d9w53MVx9QHI175Ew8lyJDgN68loYsT3UWemtdSrsRvLt8xcSqwNZf0I5hUW3mcZRuPl-cncQ2uODm_MseXuxvmpeppdvXrxqVpepzFkW0p7lBWI5UCgGRMZFD2VV9dD1kHU176sKBKVDljEuSyg7ThFqKAteDIOQ_ZCdJenBdzJ7MX8UWrd7p5YGLYV2GaSVvl0GaZdBIv_kwO-dfT-hD-2ovESthUE7RTIraF6zGBHRx7fQazs5E3-zUMDrkvI6Uo9uqKkbsf-V_nPSCJwfAOms9w6Hfwo2m78Kslu4VOHH1MEJpf8v-g4hFcTU
CitedBy_id crossref_primary_10_1007_s41030_024_00270_2
crossref_primary_10_1001_jamasurg_2023_5517
crossref_primary_10_1124_jpet_122_001493
crossref_primary_10_1016_j_lpm_2022_104160
crossref_primary_10_2337_cd21_0066
crossref_primary_10_1080_00325481_2020_1798686
crossref_primary_10_1007_s40265_021_01499_w
crossref_primary_10_1007_s11673_021_10119_x
crossref_primary_10_3389_fnut_2022_899393
crossref_primary_10_3390_kidneydial2030034
crossref_primary_10_3390_molecules28020751
crossref_primary_10_1080_17843286_2021_1952379
crossref_primary_10_2147_PPA_S496613
crossref_primary_10_4103_ijem_ijem_217_22
crossref_primary_10_4103_jfmpc_jfmpc_1401_23
crossref_primary_10_1016_j_pcd_2024_06_003
crossref_primary_10_3390_cancers13051186
crossref_primary_10_1097_MS9_0000000000002712
crossref_primary_10_1007_s12020_020_02444_9
crossref_primary_10_1016_j_jdiacomp_2020_107707
crossref_primary_10_2337_ds22_0031
crossref_primary_10_1016_j_endinu_2022_04_008
crossref_primary_10_1111_apt_17428
crossref_primary_10_18553_jmcp_2021_27_7_846
crossref_primary_10_4158_CS_2020_0490
crossref_primary_10_14309_ajg_0000000000001909
crossref_primary_10_1007_s13300_020_00850_w
crossref_primary_10_1007_s43032_024_01708_3
crossref_primary_10_1016_j_pop_2021_11_010
crossref_primary_10_1177_0272989X211049213
crossref_primary_10_17925_USE_2020_16_2_80
crossref_primary_10_1097_MED_0000000000000787
crossref_primary_10_1016_j_arteri_2021_05_002
crossref_primary_10_1080_00325481_2022_2135865
crossref_primary_10_4140_TCP_n_2022_181
crossref_primary_10_1007_s00125_023_06057_5
crossref_primary_10_4236_ijcm_2022_131002
crossref_primary_10_17269_s41997_022_00662_4
crossref_primary_10_1080_00325481_2020_1857603
crossref_primary_10_1111_eci_14214
crossref_primary_10_1002_jac5_1544
crossref_primary_10_1016_j_jacc_2020_02_018
crossref_primary_10_1080_14656566_2021_1942841
crossref_primary_10_1007_s42000_020_00256_0
crossref_primary_10_1177_13591053241241841
crossref_primary_10_1210_clinem_dgab848
crossref_primary_10_20945_2359_3997000000479
crossref_primary_10_1002_clc_23565
crossref_primary_10_1016_j_pop_2021_11_002
crossref_primary_10_1016_j_metabol_2020_154242
crossref_primary_10_1186_s13098_022_00848_3
crossref_primary_10_1177_2633559X211034486
crossref_primary_10_1097_MCA_0000000000001369
crossref_primary_10_3390_jcdd8120185
crossref_primary_10_4103_jod_jod_169_24
crossref_primary_10_1016_j_diabres_2020_108465
crossref_primary_10_1053_j_ajkd_2021_09_010
crossref_primary_10_1080_13696998_2023_2277058
crossref_primary_10_1097_MLR_0000000000001597
crossref_primary_10_1111_ijcp_13731
crossref_primary_10_1016_j_hsr_2022_100072
crossref_primary_10_5348_100073Z09HW2022CS
crossref_primary_10_1016_j_jdiacomp_2022_108389
crossref_primary_10_1097_NOR_0000000000000818
crossref_primary_10_1016_j_diabres_2020_108459
crossref_primary_10_59058_jaimc_v20i3_66
crossref_primary_10_3390_healthcare9050580
crossref_primary_10_2337_ds23_0052
crossref_primary_10_4103_JOD_JOD_81_20
crossref_primary_10_1080_00325481_2020_1798638
crossref_primary_10_3390_nu12113329
crossref_primary_10_1007_s43441_024_00637_2
crossref_primary_10_1177_20406223231161516
crossref_primary_10_1016_j_japh_2024_102295
crossref_primary_10_1097_MED_0000000000000594
crossref_primary_10_2147_PPA_S391719
crossref_primary_10_1016_j_cca_2023_117444
crossref_primary_10_3390_biomedicines9121947
crossref_primary_10_1002_cpt_2262
crossref_primary_10_3389_fendo_2021_788107
crossref_primary_10_2196_49617
crossref_primary_10_1016_j_lfs_2023_122114
crossref_primary_10_1136_bmjdrc_2021_002135
crossref_primary_10_1001_jamanetworkopen_2022_41505
crossref_primary_10_1016_j_cpcardiol_2020_100736
crossref_primary_10_1016_j_diabres_2020_108376
crossref_primary_10_1016_j_ekir_2022_09_018
crossref_primary_10_1111_dom_14904
crossref_primary_10_1186_s13075_024_03352_3
crossref_primary_10_20945_2359_3997000000319
crossref_primary_10_1111_1753_0407_13071
crossref_primary_10_2337_cd20_0121
crossref_primary_10_1111_1753_0407_13079
crossref_primary_10_1161_CIRCEP_120_009115
crossref_primary_10_1097_JXX_0000000000000516
crossref_primary_10_3389_fphys_2023_1157270
crossref_primary_10_4140_TCP_n_2021_112
crossref_primary_10_1007_s12325_020_01405_y
crossref_primary_10_1139_cjpp_2022_0065
crossref_primary_10_18553_jmcp_2020_26_11_1434
crossref_primary_10_1177_15598276221087624
crossref_primary_10_1007_s40670_024_02025_9
crossref_primary_10_3389_fendo_2022_874968
crossref_primary_10_1016_j_diabres_2023_111034
crossref_primary_10_1093_ajhp_zxaa413
crossref_primary_10_1097_MJT_0000000000001283
crossref_primary_10_1186_s13690_024_01459_2
crossref_primary_10_2337_cd22_0060
crossref_primary_10_1016_j_artere_2022_01_005
crossref_primary_10_1016_S2214_109X_21_00176_5
crossref_primary_10_1007_s12325_020_01549_x
crossref_primary_10_1111_dom_14831
crossref_primary_10_1111_dom_14953
crossref_primary_10_1097_FJC_0000000000001248
crossref_primary_10_1111_dom_14830
crossref_primary_10_1186_s13098_021_00645_4
crossref_primary_10_1111_jcpt_13381
crossref_primary_10_1007_s11892_021_01433_0
crossref_primary_10_1080_00325481_2020_1798162
crossref_primary_10_1016_j_dsx_2021_102318
crossref_primary_10_1177_2633559X211068884
crossref_primary_10_14341_DM13042
crossref_primary_10_1007_s13300_022_01356_3
crossref_primary_10_22141_2224_0721_17_8_2021_246792
crossref_primary_10_1007_s11892_021_01421_4
crossref_primary_10_1111_dom_14842
crossref_primary_10_4140_TCP_n_2022_251
crossref_primary_10_12997_jla_2022_11_1_73
crossref_primary_10_22312_sdusbed_1449989
crossref_primary_10_1007_s13300_022_01212_4
crossref_primary_10_3389_fphar_2022_831364
crossref_primary_10_1007_s00125_022_05815_1
crossref_primary_10_1007_s00592_020_01603_8
crossref_primary_10_3892_br_2025_1939
crossref_primary_10_1001_jamanetworkopen_2024_41765
crossref_primary_10_1097_JXX_0000000000000661
crossref_primary_10_1177_26350106241232649
crossref_primary_10_1002_edm2_245
crossref_primary_10_1007_s10741_022_10233_x
crossref_primary_10_1080_14656566_2021_1999413
crossref_primary_10_4140_TCP_n_2021_556
crossref_primary_10_1007_s13300_022_01247_7
crossref_primary_10_1007_s13300_021_01200_0
crossref_primary_10_1016_j_maturitas_2020_10_005
crossref_primary_10_1097_CM9_0000000000001407
crossref_primary_10_1016_j_ccl_2021_04_007
crossref_primary_10_1080_17446651_2020_1830759
crossref_primary_10_1080_00325481_2020_1788340
crossref_primary_10_2337_dc20_1964
crossref_primary_10_7759_cureus_71017
crossref_primary_10_1136_bmjopen_2023_077084
crossref_primary_10_3390_jcm12123925
crossref_primary_10_26442_00403660_2024_04_202709
crossref_primary_10_1177_08971900211010678
crossref_primary_10_2337_cd22_0020
crossref_primary_10_7759_cureus_61766
crossref_primary_10_1016_j_jdiacomp_2020_107607
crossref_primary_10_1016_j_metabol_2022_155332
crossref_primary_10_1016_j_jcjd_2023_03_002
crossref_primary_10_1161_HYPERTENSIONAHA_123_21461
crossref_primary_10_1186_s12933_021_01386_4
crossref_primary_10_1001_jamanetworkopen_2023_40232
crossref_primary_10_1111_dom_14873
crossref_primary_10_2337_cd20_0094
crossref_primary_10_2337_cd22_0016
crossref_primary_10_1007_s11695_021_05344_7
crossref_primary_10_1080_00325481_2020_1798127
crossref_primary_10_1002_jac5_1295
crossref_primary_10_1007_s13300_022_01320_1
crossref_primary_10_1093_ndt_gfac283
crossref_primary_10_1002_edm2_204
crossref_primary_10_1080_14740338_2023_2172159
crossref_primary_10_1016_j_jemep_2023_100890
crossref_primary_10_3389_fendo_2022_998210
crossref_primary_10_1007_s40200_024_01430_6
crossref_primary_10_1111_dom_14760
crossref_primary_10_1007_s13300_021_01092_0
crossref_primary_10_1111_dom_14764
crossref_primary_10_7759_cureus_68390
crossref_primary_10_1097_MD_0000000000033167
crossref_primary_10_1007_s00415_022_11112_z
crossref_primary_10_21886_2219_8075_2021_12_4_27_33
crossref_primary_10_2337_cd22_0009
crossref_primary_10_1016_j_rccar_2020_07_005
crossref_primary_10_1001_jamanetworkopen_2022_53562
crossref_primary_10_1016_j_lfs_2021_119697
crossref_primary_10_1155_2021_1010268
crossref_primary_10_1080_00325481_2020_1800286
crossref_primary_10_2147_JEP_S437991
crossref_primary_10_4239_wjd_v15_i3_331
crossref_primary_10_2174_1573399819666230116150205
crossref_primary_10_2337_dc21_2441
crossref_primary_10_3389_fendo_2022_1009095
crossref_primary_10_1210_clinem_dgad273
crossref_primary_10_1371_journal_pone_0298010
crossref_primary_10_1016_j_semnephrol_2021_03_003
crossref_primary_10_2174_1573399817666210820105514
crossref_primary_10_1007_s13300_021_01116_9
crossref_primary_10_4168_aair_2022_14_4_412
crossref_primary_10_1007_s13300_022_01355_4
crossref_primary_10_56712_latam_v4i3_1110
crossref_primary_10_1007_s13300_023_01507_0
crossref_primary_10_1111_imj_15002
crossref_primary_10_1097_XEB_0000000000000243
crossref_primary_10_2337_cd22_0027
crossref_primary_10_2337_cd20_0080
crossref_primary_10_1080_14779072_2022_2103541
crossref_primary_10_1007_s11136_020_02753_6
crossref_primary_10_1080_14656566_2021_1912734
crossref_primary_10_1080_14656566_2023_2279100
crossref_primary_10_14218_JCTH_2019_00046
crossref_primary_10_1016_j_metabol_2024_155931
crossref_primary_10_2337_cd22_0100
crossref_primary_10_1097_MS9_0000000000002494
crossref_primary_10_1007_s13300_021_01060_8
crossref_primary_10_1210_jendso_bvab019
crossref_primary_10_1089_trgh_2022_0062
crossref_primary_10_1136_bmjdrc_2021_002738
crossref_primary_10_1093_ajhp_zxad080
crossref_primary_10_4239_wjd_v15_i5_828
crossref_primary_10_3390_medsci9020038
crossref_primary_10_1016_j_amjcard_2022_10_040
crossref_primary_10_29024_jsim_78
crossref_primary_10_21518_ms2023_211
crossref_primary_10_1177_1357633X221106041
crossref_primary_10_1007_s11695_021_05637_x
crossref_primary_10_1111_dom_14684
crossref_primary_10_1016_j_amjcard_2023_03_002
crossref_primary_10_2337_ds20_0016
crossref_primary_10_19163_2307_9266_2023_11_4_324_346
crossref_primary_10_1002_hep4_1876
crossref_primary_10_1007_s13300_024_01556_z
crossref_primary_10_1056_NEJMsa2032271
crossref_primary_10_1111_dom_14205
crossref_primary_10_23736_S0022_4707_20_11105_8
crossref_primary_10_2174_1573399818666220517124752
crossref_primary_10_1007_s13300_021_01182_z
crossref_primary_10_1177_08971900221087933
crossref_primary_10_21518_ms2023_466
crossref_primary_10_1080_00325481_2022_2126235
crossref_primary_10_1016_j_dsx_2024_103066
crossref_primary_10_1111_dom_14530
crossref_primary_10_3390_jcm11071826
crossref_primary_10_1056_NEJMcp2000280
crossref_primary_10_1161_JAHA_121_023489
crossref_primary_10_1016_j_eprac_2022_08_002
crossref_primary_10_1186_s12933_020_01169_3
crossref_primary_10_1007_s13300_023_01414_4
crossref_primary_10_1016_j_amjcard_2023_12_034
crossref_primary_10_1136_jim_2021_002268
crossref_primary_10_4103_ijdt_ijdt_15_23
crossref_primary_10_1111_dom_15993
crossref_primary_10_2337_cd23_0047
crossref_primary_10_2337_dc22_1915
crossref_primary_10_4103_ijem_ijem_522_21
crossref_primary_10_2174_0113816128306300240522074056
crossref_primary_10_1186_s12933_021_01287_6
crossref_primary_10_1016_j_anclin_2023_08_004
crossref_primary_10_1111_odi_14931
crossref_primary_10_1186_s12933_021_01428_x
crossref_primary_10_3389_fcvm_2022_861110
crossref_primary_10_1016_j_dsx_2023_102901
crossref_primary_10_1007_s13300_021_01062_6
crossref_primary_10_1097_JXX_0000000000001060
crossref_primary_10_1111_dom_15443
crossref_primary_10_1007_s11428_021_00817_w
crossref_primary_10_1007_s13300_022_01340_x
crossref_primary_10_4236_jdm_2021_115018
crossref_primary_10_1016_j_diabres_2022_109821
crossref_primary_10_1016_j_endmts_2021_100102
crossref_primary_10_1111_dom_15339
crossref_primary_10_1089_dia_2025_0050
crossref_primary_10_1002_dmrr_3416
crossref_primary_10_1007_s11033_022_07254_y
crossref_primary_10_1080_14740338_2021_1954158
crossref_primary_10_1007_s11892_021_01408_1
crossref_primary_10_1186_s13063_024_08267_7
crossref_primary_10_1055_s_0044_1791692
crossref_primary_10_1016_j_eprac_2023_02_001
crossref_primary_10_1007_s13300_024_01610_w
crossref_primary_10_2196_43669
crossref_primary_10_1016_j_endien_2023_07_001
crossref_primary_10_1007_s11096_024_01828_5
crossref_primary_10_1097_EBP_0000000000001324
crossref_primary_10_4236_jdm_2023_132017
crossref_primary_10_1001_jamanetworkopen_2021_28782
crossref_primary_10_2196_42664
crossref_primary_10_1016_S2213_8587_21_00245_X
crossref_primary_10_1186_s12933_021_01297_4
crossref_primary_10_4103_cdrp_cdrp_9_22
crossref_primary_10_1016_j_dsx_2024_103157
crossref_primary_10_1111_dom_14464
crossref_primary_10_1111_dom_14466
crossref_primary_10_2337_dc20_1402
crossref_primary_10_1161_CIRCULATIONAHA_120_045888
crossref_primary_10_1016_j_ejim_2021_11_008
crossref_primary_10_2147_CLEP_S487825
crossref_primary_10_1007_s40200_024_01406_6
crossref_primary_10_1016_j_diabres_2023_110626
crossref_primary_10_1177_0897190020958245
crossref_primary_10_1177_1179551420984130
crossref_primary_10_1016_j_soard_2021_08_024
crossref_primary_10_1210_clinem_dgac644
crossref_primary_10_3389_fcdhc_2021_658817
crossref_primary_10_1016_j_ejphar_2021_173934
crossref_primary_10_1097_HCO_0000000000000873
crossref_primary_10_1016_j_jdiacomp_2021_108101
crossref_primary_10_1097_MED_0000000000000802
crossref_primary_10_1007_s13300_024_01661_z
crossref_primary_10_1001_jamainternmed_2022_6664
crossref_primary_10_1016_j_med_2020_09_021
crossref_primary_10_3389_fendo_2022_851035
crossref_primary_10_1515_jom_2021_0035
crossref_primary_10_1007_s13300_022_01286_0
crossref_primary_10_1007_s40619_022_01103_7
crossref_primary_10_1002_ehf2_13811
crossref_primary_10_1016_j_jacc_2024_05_069
crossref_primary_10_1111_dom_14047
crossref_primary_10_1136_bmj_n1091
crossref_primary_10_14341_DM12864
crossref_primary_10_21518_ms2024_409
crossref_primary_10_1093_jamiaopen_ooab101
crossref_primary_10_1016_j_diabres_2020_108389
crossref_primary_10_22141_2224_0721_19_3_2023_1277
crossref_primary_10_1136_bmjdrc_2021_002320
crossref_primary_10_1089_dia_2023_0365
crossref_primary_10_2337_cd21_0119
crossref_primary_10_3390_jcm10194497
crossref_primary_10_1186_s13098_022_00942_6
crossref_primary_10_1080_00325481_2021_1971461
crossref_primary_10_1177_15598276221130684
crossref_primary_10_7759_cureus_46510
crossref_primary_10_1111_dom_14259
crossref_primary_10_1111_jdi_13764
crossref_primary_10_2337_ds20_0067
crossref_primary_10_4103_jod_jod_71_21
crossref_primary_10_1016_j_jcte_2024_100370
crossref_primary_10_4103_JOD_JOD_59_20
crossref_primary_10_1016_j_semerg_2021_04_011
crossref_primary_10_3389_fphar_2022_886834
crossref_primary_10_1177_11795514221074663
crossref_primary_10_1136_bmjdrc_2020_002032
crossref_primary_10_3390_jpm12111915
crossref_primary_10_1080_00325481_2022_2147326
crossref_primary_10_1038_s41598_023_46274_x
crossref_primary_10_1016_j_ahjo_2022_100163
crossref_primary_10_1007_s40200_023_01296_0
crossref_primary_10_1007_s11154_022_09735_8
crossref_primary_10_1210_clinem_dgad745
crossref_primary_10_2147_DDDT_S302215
crossref_primary_10_5348_100073Z09HW2023CS
crossref_primary_10_1002_cpt_2073
crossref_primary_10_1053_j_ackd_2021_02_001
crossref_primary_10_1186_s13098_023_01245_0
crossref_primary_10_1111_ajt_17049
crossref_primary_10_1016_j_jacc_2023_04_052
crossref_primary_10_1016_j_jacc_2022_02_046
crossref_primary_10_1371_journal_pone_0309365
crossref_primary_10_34922_AE_2023_36_4_013
crossref_primary_10_17925_EE_2022_18_2_106
crossref_primary_10_20960_nh_04204
crossref_primary_10_61661_BJLM_2023_v2_86
crossref_primary_10_1055_s_0042_1755440
crossref_primary_10_1007_s10557_022_07360_w
crossref_primary_10_1186_s12889_023_15763_z
crossref_primary_10_1016_j_diabres_2023_110836
crossref_primary_10_1007_s11886_021_01503_5
crossref_primary_10_1155_2022_5318245
crossref_primary_10_1016_j_mayocp_2022_05_003
crossref_primary_10_1111_jebm_12474
crossref_primary_10_1111_1753_0407_13213
crossref_primary_10_1186_s12933_022_01520_w
crossref_primary_10_1002_dmrr_3495
crossref_primary_10_1007_s11892_021_01382_8
crossref_primary_10_3390_nu15234943
crossref_primary_10_1038_s41540_023_00275_8
crossref_primary_10_1007_s13340_020_00473_3
crossref_primary_10_1007_s11883_022_01031_9
crossref_primary_10_2147_DMSO_S334944
crossref_primary_10_61661_BJLM_2024_v3_89
crossref_primary_10_1007_s13300_022_01294_0
crossref_primary_10_1177_19322968221148756
crossref_primary_10_21615_cesmedicina_6672
crossref_primary_10_1097_01_JAA_0000669452_63883_45
crossref_primary_10_3390_biology10010018
crossref_primary_10_2174_0118715303282327240507184902
crossref_primary_10_17925_EE_2022_18_1_63
crossref_primary_10_1007_s40618_024_02369_4
crossref_primary_10_4103_jfmpc_jfmpc_2378_20
crossref_primary_10_1007_s11886_024_02055_0
crossref_primary_10_3349_ymj_2022_63_6_539
crossref_primary_10_1016_j_cpcardiol_2021_100878
crossref_primary_10_1016_j_focus_2023_100118
crossref_primary_10_1038_s41598_021_89827_8
crossref_primary_10_1016_j_ijcard_2022_07_041
crossref_primary_10_1080_17434440_2021_1992274
crossref_primary_10_1016_j_phanu_2023_100363
crossref_primary_10_7759_cureus_18155
crossref_primary_10_1177_2042018821997320
crossref_primary_10_14341_DM12802
crossref_primary_10_1016_j_eprac_2021_05_007
crossref_primary_10_1007_s40262_020_00951_6
crossref_primary_10_1016_j_jsps_2022_01_018
crossref_primary_10_1001_jamacardio_2020_4511
crossref_primary_10_4103_jfmpc_jfmpc_1206_21
Cites_doi 10.1056/NEJMoa1107579
10.1016/j.beem.2009.03.003
10.1111/j.1463-1326.2009.01181.x
10.1007/s00125-009-1472-y
10.2337/dc09-1278
10.1001/jama.298.10.1180
10.4158/EP151124.CS
10.1001/archinternmed.2012.3147
10.1016/j.amjmed.2011.08.008
10.4158/EP15672.GLSUPPL
10.2337/dc07-2137
10.1056/NEJMoa0802743
10.1056/NEJMoa1501352
10.1016/S0140-6736(02)09327-3
10.4158/EP161292.PS
10.1016/S0140-6736(98)04311-6
10.1016/S0140-6736(11)60205-5
10.4103/0022-3859.123143
10.2337/diacare.28.2.254
10.2337/dc08-9018
10.2147/DDDT.S50773
10.1038/oby.2000.48
10.1001/archinte.165.8.936
10.2165/11535380-000000000-00000
10.1001/jama.2013.284427
10.1111/j.1365-2796.2005.01528.x
10.1016/S0140-6736(17)30069-7
10.1056/NEJMoa1615664
10.4158/EP.14.7.933
10.1111/j.1463-1326.2008.00967.x
10.1016/j.ejphar.2015.03.099
10.2337/dc13-1518
10.1016/j.amjmed.2013.09.018
10.1093/sleep/32.6.772
10.1016/S0140-6736(10)60576-4
10.1161/CIRCULATIONAHA.109.865840
10.2337/dc07-0048
10.1111/j.1463-1326.2012.01603.x
10.1056/NEJMoa1611925
10.1016/j.diabres.2014.08.011
10.2337/diacare.23.7.888
10.1097/FJC.0b013e31823a109f
10.1016/j.atherosclerosis.2009.03.029
10.2337/dc14-0006
10.4158/EP14280.PS
10.1056/NEJMc1006407
10.1056/NEJMoa1411892
10.1056/NEJMoa1316222
10.2147/DMSO.S28340
10.2337/dc11-s237
10.1093/ajcn/80.6.1461
10.1038/ijo.2011.158
10.1016/S0140-6736(19)31149-3
10.1056/NEJM199602293340906
10.2337/dc15-0843
10.1056/NEJMoa1812389
10.2337/dc09-2009
10.1056/NEJMoa1001288
10.1056/NEJMoa1501031
10.1056/NEJMoa1410489
10.1177/193229681300700323
10.2337/dc05-2465
10.1517/17425255.2015.1058779
10.1042/cs1010671
10.2337/dc11-1928
10.1056/NEJMoa0909809
10.1016/S0140-6736(02)08089-3
10.1007/s12325-016-0370-1
10.4158/EP12160.PS
10.1161/01.CIR.0000115514.44135.A8
10.2337/dc10-1548
10.1002/oby.20309
10.1038/oby.2007.512
10.1056/NEJMoa0806182
10.1037/0022-006X.56.4.529
10.1016/S0195-668X(03)00468-8
10.1056/NEJMoa1500858
10.1056/NEJMp1001578
10.1016/j.amjcard.2004.03.023
10.1056/NEJMoa0802987
10.1016/j.atherosclerosis.2008.06.003
10.1056/NEJMoa1607141
10.1515/cclm-2013-0358
10.1056/NEJMoa1001282
10.1056/NEJM200101043440101
10.1056/NEJMoa1307684
10.2337/dc12-1205
10.1093/eurheartj/ehr007
10.1016/S0140-6736(05)67663-5
10.1161/CIRCULATIONAHA.111.026567
10.1185/03007991003634759
10.1001/archinte.160.14.2150
10.1001/jama.297.6.611
10.1007/s00125-009-1354-3
10.1136/bmj.b4909
10.1056/NEJMoa012512
10.1111/j.1463-1326.2011.01459.x
10.1056/NEJMoa1603827
10.2337/diacare.28.4.888
10.1056/NEJMoa1205409
10.2337/dc10-0125
10.2337/dc11-0064
10.2337/diacare.24.6.1069
10.1111/j.1365-2362.2009.02163.x
10.1016/j.jacl.2007.12.006
10.2337/dc07-2270
10.1016/S0140-6736(10)60888-4
10.1161/CIRCULATIONAHA.106.174516
10.1016/j.jacc.2014.02.615
10.1056/NEJMoa1509225
10.1056/NEJMoa1811744
10.1056/NEJMoa1911303
10.1161/CIRCULATIONAHA.110.016337
10.1016/S0140-6736(05)67528-9
10.1016/S0140-6736(08)61242-8
10.1007/s13668-014-0094-2
10.1155/2012/918571
10.1001/archinte.163.2.205
10.1016/j.atherosclerosis.2008.09.026
10.1097/HJH.0b013e32832d7370
10.1016/j.atherosclerosis.2011.04.020
10.1056/NEJMoa1504720
10.1016/j.diabres.2008.04.007
10.1016/S0140-6736(12)60205-0
10.1056/NEJMra040832
10.1093/ajcn/69.2.198
10.1016/S0140-6736(06)69420-8
10.2337/dc13-3055
10.1001/archinte.159.16.1893
10.2337/dc12-1668
10.2337/dc13-2042
10.1111/1753-0407.12065
10.2337/dc05-2415
10.1001/archinternmed.2010.380
10.1016/j.amjcard.2004.09.013
10.7326/0003-4819-154-2-201101180-00300
10.1056/NEJMoa1303154
10.1159/000497124
10.1016/S0140-6736(10)61350-5
10.1089/dia.2017.0090
10.1056/NEJMoa1010949
10.1056/NEJMoa1615692
10.1056/NEJMoa1001286
10.1007/s00125-002-1009-0
10.1037/0022-006X.64.1.172
10.1001/archinternmed.2009.56
10.1046/j.1463-1326.2002.00205.x
10.1056/NEJMoa066224
10.1111/dme.12144
10.1016/S0140-6736(03)12948-0
10.1016/S0140-6736(02)08905-5
10.1056/NEJM199908053410604
10.1249/MSS.0b013e3181b3b16d
10.1056/NEJMoa1006524
10.1001/jama.292.11.1307
10.2337/dc15-1251
10.7326/0003-4819-147-6-200709180-00178
10.1056/NEJMoa1812792
10.1016/S0140-6736(09)60953-3
10.2190/KLGD-4H8D-4RYL-TWQ8
10.2337/dc14-0930
10.1016/j.ecl.2012.03.004
10.1210/jc.2011-1256
10.2337/dc14-0991
10.2337/dc09-1519
10.4158/EP161365.GL
10.2337/dc10-2361
10.1016/j.jdiacomp.2013.04.008
10.1164/ajrccm.164.11.2102028
10.1185/03007995.2012.665046
10.4158/EP13155.GL
10.1056/NEJMoa1414266
10.7326/0003-4819-135-12-200112180-00005
10.1097/01.ASN.0000123691.46138.E2
10.1001/jama.289.17.2254
10.2337/diacare.27.1.155
10.4158/EP12437.GL
10.1056/NEJMoa1300955
10.1111/j.1532-5415.2012.03998.x
10.4158/EP13005.RA
10.1016/j.cger.2014.09.002
10.2337/diacare.25.2.330
10.2337/diacare.28.4.950
10.1016/j.jacc.2015.08.035
10.1016/j.atherosclerosis.2014.05.914
10.1016/S0140-6736(02)11600-X
10.2337/dc07-0183
10.4158/PS-2019-0080
10.1210/jc.2010-0892
10.1056/NEJMoa0808431
10.1001/jama.2015.7996
10.1038/oby.2011.330
10.2337/dc08-1543
10.1177/1932296815581052
10.1016/S0140-6736(18)32261-X
10.2337/db09-9028
10.1111/dom.12573
10.2337/dc09-0606
10.1093/aje/kwj280
10.1210/jc.2015-1520
10.1161/JAHA.112.002279
10.1093/sleep/29.8.1009
10.4158/EP171764.APPGL
10.1111/j.1463-1326.2010.01306.x
10.4158/EP13263.RA
10.1038/oby.2010.147
10.1016/S0140-6736(04)16895-5
10.1161/circ.106.25.3143
10.4161/isl.2.2.10582
10.1007/s00125-017-4301-8
10.1007/s10557-005-5686-z
10.1001/jama.2017.6939
10.1016/j.jacc.2006.04.070
10.1161/CIR.0000000000000558
10.7326/0003-4819-157-9-201211060-00003
10.1016/j.jcjd.2013.02.060
10.1016/S0140-6736(09)61457-4
10.1016/S2213-8587(19)30068-3
10.4158/EP15653.CS
10.1161/CIRCULATIONAHA.114.010389
10.1056/NEJMoa1305889
10.2337/diacare.26.11.3080
10.1177/000331970305400607
10.1056/NEJMoa1003795
10.1177/1479164112465442
10.2337/dc06-2495
10.2337/dc12-2329
10.1056/NEJM199211123272005
10.1038/ijo.2013.120
10.1016/j.ypmed.2003.11.027
10.1186/s12916-015-0358-8
10.1056/NEJM198711123172001
10.2337/diabetes.52.1.102
10.1056/NEJMoa1506930
10.2337/dc07-9917
10.1093/eurheartj/ehl220
10.2337/db10-1392
10.1007/s00125-007-0599-y
10.1161/01.CIR.85.1.37
10.7326/0003-4819-156-6-201203200-00003
10.1038/oby.2008.637
10.1056/NEJMoa1203859
10.1016/S2213-8587(13)70191-8
10.1037/0022-006X.67.2.260
10.1038/oby.2000.31
10.1016/S0140-6736(08)60104-X
10.2337/dc05-1365
10.2337/diacare.28.12.2823
10.2337/dc13-0234
10.1016/S0306-4603(97)00016-6
10.1056/NEJMoa1612917
10.1016/j.jacc.2005.02.080
10.2337/diabetes.54.4.1150
10.1016/j.clinthera.2014.11.008
10.1038/oby.2012.66
10.4158/EP161688.PS
10.1111/j.1365-2796.2006.01616.x
10.1161/01.CIR.0000133317.49796.0E
10.1016/S0140-6736(14)62225-X
10.1038/nrendo.2017.77
10.2337/dc09-0228
10.1210/jc.2005-2226
10.1016/j.jacl.2011.02.001
10.1016/S0002-9343(96)00319-1
10.1001/jama.1997.03540440058033
10.2337/dc11-1582
10.1097/FJC.0b013e318202709f
10.1016/S0140-6736(07)60527-3
10.3945/ajcn.111.024927
10.1056/NEJMp1309610
10.1016/S0140-6736(99)12323-7
10.1249/01.mss.0000235352.09061.1d
10.1016/S0140-6736(09)61375-1
10.1001/jama.2010.405
10.4158/PS-2018-0139
10.1016/j.jacc.2012.10.030
10.1111/j.1463-1326.2009.01173.x
10.1001/jama.290.4.486
10.1056/NEJMoa1208799
10.1001/jama.2010.1710
10.1111/j.1463-1326.2010.01232.x
ContentType Journal Article
Copyright Copyright Allen Press Publishing Services Jan 2020
Copyright_xml – notice: Copyright Allen Press Publishing Services Jan 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88C
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
FYUFA
GHDGH
K9-
K9.
KB0
M0R
M0S
M0T
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
ADTOC
UNPAY
DOI 10.4158/CS-2019-0472
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
Consumer Health Database (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database
ProQuest Health & Medical Collection
Healthcare Administration Database
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1934-2403
EndPage 139
ExternalDocumentID 10.4158/cs-2019-0472
32022600
10_4158_CS_2019_0472
Genre Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
0R~
4.4
53G
5GY
7RV
7X7
88E
8FI
8FJ
AALRI
AAQQT
AAXUO
AAYXX
ABJNI
ABUWG
ADBBV
AENEX
AFFHD
AFJKZ
AFKRA
AHMBA
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
AQUVI
AZQEC
BENPR
BKEYQ
BKNYI
BPHCQ
BVXVI
CCPQU
CITATION
EBS
EFKBS
EJD
F5P
FDB
FYUFA
HMCUK
K9-
M0R
M0T
M1P
MAS
MCE
MET
NAPCQ
OVD
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
ROL
TEORI
UKHRP
AGCQF
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
ADTOC
UNPAY
ID FETCH-LOGICAL-c423t-d245ee6f105fee28ad0677d0bd03b98d770a11f3328c606b81e0906585ffacdf3
IEDL.DBID BENPR
ISSN 1530-891X
1934-2403
IngestDate Tue Aug 19 21:37:35 EDT 2025
Sat Sep 27 23:21:56 EDT 2025
Tue Oct 07 06:42:39 EDT 2025
Mon Jul 21 06:08:37 EDT 2025
Wed Oct 29 21:24:06 EDT 2025
Thu Apr 24 22:56:03 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c423t-d245ee6f105fee28ad0677d0bd03b98d770a11f3328c606b81e0906585ffacdf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=http://www.endocrinepractice.org/article/S1530891X20350667/pdf
PMID 32022600
PQID 2350896189
PQPubID 1896353
PageCount 33
ParticipantIDs unpaywall_primary_10_4158_cs_2019_0472
proquest_miscellaneous_2351492065
proquest_journals_2350896189
pubmed_primary_32022600
crossref_primary_10_4158_CS_2019_0472
crossref_citationtrail_10_4158_CS_2019_0472
PublicationCentury 2000
PublicationDate 2020-01-00
20200101
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Jacksonville
PublicationTitle Endocrine practice
PublicationTitleAlternate Endocr Pract
PublicationYear 2020
Publisher Elsevier Limited
Publisher_xml – name: Elsevier Limited
References Toth (10.4158/CS-2019-0472_bb0635) 2014; 235
Ridker (10.4158/CS-2019-0472_bb0595) 2007; 297
Christian (10.4158/CS-2019-0472_bb0880) 2014; 127
Hayward (10.4158/CS-2019-0472_bb0925) 2015; 372
DeFronzo (10.4158/CS-2019-0472_bb0405) 2011; 364
Home (10.4158/CS-2019-0472_bb1295) 2010; 12
Keogh (10.4158/CS-2019-0472_bb0075) 2012; 2012
Allison (10.4158/CS-2019-0472_bb0305) 2012; 20
Pan (10.4158/CS-2019-0472_bb0820) 2002; 4
Ayas (10.4158/CS-2019-0472_bb0190) 2003; 163
Shepherd (10.4158/CS-2019-0472_bb0605) 2002; 360
Sniderman (10.4158/CS-2019-0472_bb0690) 2008; 2
Phung (10.4158/CS-2019-0472_bb1230) 2010; 303
Handelsman (10.4158/CS-2019-0472_bb1120) 2016; 22
Flechtner-Mors (10.4158/CS-2019-0472_bb0085) 2000; 8
Mechanick (10.4158/CS-2019-0472_bb0360) 2013; 19
Grunberger (10.4158/CS-2019-0472_bb1475) 2015; 21
Rubins (10.4158/CS-2019-0472_bb0780) 1999; 341
Roumie (10.4158/CS-2019-0472_bb0950) 2012; 157
Arnolds (10.4158/CS-2019-0472_bb1405) 2013; 7
McGill (10.4158/CS-2019-0472_bb1465) 2017; 19
Zinman (10.4158/CS-2019-0472_bb1340) 2012; 35
Butler (10.4158/CS-2019-0472_bb0010) 2003; 52
Colberg (10.4158/CS-2019-0472_bb0160) 2010; 33
Stewart (10.4158/CS-2019-0472_bb0485) 2001
Sever (10.4158/CS-2019-0472_bb0600) 2003; 361
Cryer (10.4158/CS-2019-0472_bb1460) 2011; 124
Pop-Busui (10.4158/CS-2019-0472_bb0910) 2010; 33
Rosenstock (10.4158/CS-2019-0472_bb1265) 2013; 27
Owens (10.4158/CS-2019-0472_bb1410) 2011; 13
Astrup (10.4158/CS-2019-0472_bb0345) 2012; 36
Yusuf (10.4158/CS-2019-0472_bb0260) 2005; 366
Shepherd (10.4158/CS-2019-0472_bb0680) 2006; 29
Oikawa (10.4158/CS-2019-0472_bb0850) 2009; 206
Astrup (10.4158/CS-2019-0472_bb0350) 2009; 374
Diabetes Prevention Program Research Group (10.4158/CS-2019-0472_bb0390) 2009; 374
Sleight (10.4158/CS-2019-0472_bb0430) 2009; 27
Wiviott (10.4158/CS-2019-0472_bb1065) 2019; 380
Praet (10.4158/CS-2019-0472_bb0135) 2006; 38
Forst (10.4158/CS-2019-0472_bb1235) 2013; 10
Mechanick (10.4158/CS-2019-0472_bb0030) 2018; 24
Hoskin (10.4158/CS-2019-0472_bb0055) 2014; 3
Handelsman (10.4158/CS-2019-0472_bb0035) 2015; 21
Patel (10.4158/CS-2019-0472_bb0175) 2006; 164
Sun (10.4158/CS-2019-0472_bb1000) 2015; 37
Bolen (10.4158/CS-2019-0472_bb1190) 2007; 147
McGill (10.4158/CS-2019-0472_bb1395) 2016; 33
Hutton (10.4158/CS-2019-0472_bb0270) 2004; 80
Lipska (10.4158/CS-2019-0472_bb1400) 2017; 318
le Roux (10.4158/CS-2019-0472_bb0375) 2017; 389
Umpierrez (10.4158/CS-2019-0472_bb1110) 2017; 13
Lipska (10.4158/CS-2019-0472_bb0970) 2011; 34
Balducci (10.4158/CS-2019-0472_bb0120) 2007; 30
ADVANCE Collaborative Group (10.4158/CS-2019-0472_bb0885) 2008; 358
Veterans Affairs Diabetes Trial Investigators (10.4158/CS-2019-0472_bb0920) 2009; 360
Otvos (10.4158/CS-2019-0472_bb0640) 2011; 5
Church (10.4158/CS-2019-0472_bb0145) 2010; 304
Ferwana (10.4158/CS-2019-0472_bb1205) 2013; 30
Garvey (10.4158/CS-2019-0472_bb0295) 2012; 95
Handelsman (10.4158/CS-2019-0472_bb0760) 2011; 34
10.4158/CS-2019-0472_bb0750
Zhang (10.4158/CS-2019-0472_bb0725) 2015; 13
Erondu (10.4158/CS-2019-0472_bb1115) 2015; 38
Devries (10.4158/CS-2019-0472_bb1260) 2012; 35
Colhoun (10.4158/CS-2019-0472_bb0645) 2004; 364
Fried (10.4158/CS-2019-0472_bb0535) 2013; 369
Zinman (10.4158/CS-2019-0472_bb1055) 2015; 373
HPS2-THRIVE Collaborative Group (10.4158/CS-2019-0472_bb0830) 2014; 371
(10.4158/CS-2019-0472_bb1130) 2018
Zannad (10.4158/CS-2019-0472_bb1160) 2015; 385
DeFronzo (10.4158/CS-2019-0472_bb1170) 2009; 58
Blackberry (10.4158/CS-2019-0472_bb1280) 2014; 106
Ridker (10.4158/CS-2019-0472_bb0565) 2005; 45
Yki-Järvinen (10.4158/CS-2019-0472_bb1355) 1992; 327
Cannon (10.4158/CS-2019-0472_bb0685) 2006; 48
Wile (10.4158/CS-2019-0472_bb0985) 2010; 33
Chaput (10.4158/CS-2019-0472_bb0185) 2007; 15
Harkness (10.4158/CS-2019-0472_bb0220) 2010; 33
Davies (10.4158/CS-2019-0472_bb1045) 2016; 8
DREAM (Diabetes REduction Assessment with rampipril and rosiglitazone Medication) Trial Investigators (10.4158/CS-2019-0472_bb0395) 2006; 368
Lavigne (10.4158/CS-2019-0472_bb0835) 2013; 61
Gerstein (10.4158/CS-2019-0472_bb1020) 2019; 394
Bruckert (10.4158/CS-2019-0472_bb0695) 2005; 19
Singh (10.4158/CS-2019-0472_bb0990) 2013; 59
Jellinger (10.4158/CS-2019-0472_bb0630) 2017; 23
Scirica (10.4158/CS-2019-0472_bb1150) 2013; 369
Cappuccio (10.4158/CS-2019-0472_bb0170) 2011; 32
Balducci (10.4158/CS-2019-0472_bb0150) 2010; 170
Sacks (10.4158/CS-2019-0472_bb0465) 2001; 344
Pfeffer (10.4158/CS-2019-0472_bb1030) 2015; 373
Marso (10.4158/CS-2019-0472_bb1015) 2016; 375
Vilsbøll (10.4158/CS-2019-0472_bb1385) 2010; 12
Benjamin (10.4158/CS-2019-0472_bb0540) 2018; 137
Cholesterol Treatment Trialists (CTT) Collaborators (10.4158/CS-2019-0472_bb0660) 2008; 371
Riddle (10.4158/CS-2019-0472_bb1320) 2014; 37
Heart Outcomes Prevention Evaluation Study Investigators (10.4158/CS-2019-0472_bb0495) 2000; 355
Bonds (10.4158/CS-2019-0472_bb0935) 2010; 340
Holman (10.4158/CS-2019-0472_bb1035) 2017; 377
Wadden (10.4158/CS-2019-0472_bb0330) 2011; 19
Leahy (10.4158/CS-2019-0472_bb1420) 2012; 41
Masuda (10.4158/CS-2019-0472_bb0700) 2009; 39
(10.4158/CS-2019-0472_bb1010) 2017
Bosch (10.4158/CS-2019-0472_bb0865) 2012; 367
ACCORD Study Group (10.4158/CS-2019-0472_bb0785) 2010; 362
STOP-NIDDM Trial Research Group (10.4158/CS-2019-0472_bb0380) 2003; 290
Dormandy (10.4158/CS-2019-0472_bb0410) 2005; 366
Costanzo (10.4158/CS-2019-0472_bb0480) 2010; 121
Hansen (10.4158/CS-2019-0472_bb0130) 2009; 52
(10.4158/CS-2019-0472_bb1070) 2018
Hirsch (10.4158/CS-2019-0472_bb1390) 2005; 352
Gottlieb (10.4158/CS-2019-0472_bb0180) 2006; 29
Apovian (10.4158/CS-2019-0472_bb0320) 2013; 21
Sbrocco (10.4158/CS-2019-0472_bb0090) 1999; 67
Ahmed (10.4158/CS-2019-0472_bb0670) 2006; 27
Hanefeld (10.4158/CS-2019-0472_bb1225) 2004; 25
Moghissi (10.4158/CS-2019-0472_bb1445) 2013; 19
Rosenstock (10.4158/CS-2019-0472_bb1285) 2005; 28
Gonzalez-Campoy (10.4158/CS-2019-0472_bb0115) 2013; 19
Cholesterol Treatment Trialists (CTT) Collaboration (10.4158/CS-2019-0472_bb0655) 2010; 376
Fidler (10.4158/CS-2019-0472_bb0290) 2011; 96
Heart Protection Study Collaborative Group (10.4158/CS-2019-0472_bb0560) 2002; 360
Reinstatler (10.4158/CS-2019-0472_bb0975) 2012; 35
Hermansen (10.4158/CS-2019-0472_bb1275) 2006; 29
Diabetes Prevention Program Research Group (10.4158/CS-2019-0472_bb0400) 2005; 54
Greenway (10.4158/CS-2019-0472_bb0335) 2010; 376
Bhatt (10.4158/CS-2019-0472_bb0870) 2019; 380
Ditschuneit (10.4158/CS-2019-0472_bb0080) 1999; 69
Brunzell (10.4158/CS-2019-0472_bb0575) 2008; 31
Sabatine (10.4158/CS-2019-0472_bb0715) 2015; 372
Deacon (10.4158/CS-2019-0472_bb0995) 2012; 14
Stevens (10.4158/CS-2019-0472_bb0615) 2001; 101
Canner (10.4158/CS-2019-0472_bb0840) 2005; 95
Diabetes Prevention Program Research Group (10.4158/CS-2019-0472_bb0370) 2002; 346
Insulin Glargine Study Investigators (10.4158/CS-2019-0472_bb1270) 2003; 26
Metz (10.4158/CS-2019-0472_bb0110) 2000; 160
Grundy (10.4158/CS-2019-0472_bb0580) 2004; 110
Robinson (10.4158/CS-2019-0472_bb0710) 2015; 372
Sacks (10.4158/CS-2019-0472_bb0805) 2010; 363
Boden (10.4158/CS-2019-0472_bb0825) 2011; 365
STOP-NIDDM Trial Research Group (10.4158/CS-2019-0472_bb0385) 2002; 359
Vinik (10.4158/CS-2019-0472_bb0915) 2010; 95
DeWitt (10.4158/CS-2019-0472_bb1440) 2003; 289
Hollander (10.4158/CS-2019-0472_bb0325) 2013; 36
Scott (10.4158/CS-2019-0472_bb0800) 2009; 32
Bruckert (10.4158/CS-2019-0472_bb0795) 2011; 57
Rosenstock (10.4158/CS-2019-0472_bb1365) 2014; 37
Kernan (10.4158/CS-2019-0472_bb0415) 2016; 374
Wright (10.4158/CS-2019-0472_bb1430) 2002; 25
Kip (10.4158/CS-2019-0472_bb0255) 2004; 109
Smith (10.4158/CS-2019-0472_bb0610) 2006; 113
Scirica (10.4158/CS-2019-0472_bb1165) 2014; 130
Gehlaut (10.4158/CS-2019-0472_bb1450) 2015; 9
Knopp (10.4158/CS-2019-0472_bb0650) 2006; 29
Garvey (10.4158/CS-2019-0472_bb0240) 2016; 22
Manninen (10.4158/CS-2019-0472_bb0790) 1992; 85
Ismail-Beigi (10.4158/CS-2019-0472_bb0890) 2010; 376
McNeil (10.4158/CS-2019-0472_bb0165) 2013; 37
Gaziano (10.4158/CS-2019-0472_bb1250) 2010; 33
Meyers (10.4158/CS-2019-0472_bb0100) 1996; 64
Davies (10.4158/CS-2019-0472_bb1310) 2016; 18
Bailey (10.4158/CS-2019-0472_bb0940) 1996; 334
Kahn (10.4158/CS-2019-0472_bb1195) 2008; 31
Stone (10.4158/CS-2019-0472_bb0620) 1996; 101
De Feyter (10.4158/CS-2019-0472_bb0140) 2007; 30
Pahor (10.4158/CS-2019-0472_bb0520) 2000; 23
Yokoyama (10.4158/CS-2019-0472_bb0845) 2007; 369
Hernandez (10.4158/CS-2019-0472_bb1025) 2018; 392
Valencia-Flores (10.4158/CS-2019-0472_bb0205) 2000; 8
Athyros (10.4158/CS-2019-0472_bb0665) 2003; 54
Lewis (10.4158/CS-2019-0472_bb1215) 2015; 314
White (10.4158/CS-2019-0472_bb1145) 2013; 369
Rahman (10.4158/CS-2019-0472_bb0510) 2005; 165
Boekholdt (10.4158/CS-2019-0472_bb0550) 2014; 64
Bray (10.4158/CS-2019-0472_bb0250) 2012; 125
Manders (10.4158/CS-2019-0472_bb0125) 2010; 42
Frühbeck (10.4158/CS-2019-0472_bb0225) 2019; 12
Action to Control Cardiovascular Risk in Diabetes Study Group (10.4158/CS-2019-0472_bb0900) 2008; 358
Parks (10.4158/CS-2019-0472_bb1050) 2010; 362
Smith (10.4158/CS-2019-0472_bb0280) 2010; 363
National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A (10.4158/CS-2019-0472_bb0545) 2002; 106
Mechanick (10.4158/CS-2019-0472_bb0235) 2012; 18
Pi-Sunyer (10.4158/CS-2019-0472_bb0355) 2015; 373
Hansson (10.4158/CS-2019-0472_bb0500) 1998; 351
Winkelman (10.4158/CS-2019-0472_bb0200) 2009; 32
Liese (10.4158/CS-2019-0472_bb0460) 2009; 32
Peyrot (10.4158/CS-2019-0472_bb1425) 2010; 26
Mechanick (10.4158/CS-2019-0472_bb0060) 2019; 25
Riddle (10.4158/CS-2019-0472_bb0905) 2010; 33
Whelton (10.4158/CS-2019-0472_bb0440) 1997; 277
Gaziano (10.4158/CS-2019-0472_bb1255) 2012; 1
U.S. Food and Drug Administration (10.4158/CS-2019-0472_bb0960) 2016
Ramasamy (10.4158/CS-2019-0472_bb0720) 2014; 52
Wilding (10.4158/CS-2019-0472_bb1360) 2012; 156
Roncaglioni (10.4158/CS-2019-0472_bb0860) 2013; 368
Perri (10.4158/CS-2019-0472_bb0105) 1988; 56
Defronzo (10.4158/CS-2019-0472_bb1245) 2011; 34
Torgerson (10.4158/CS-2019-0472_bb0275) 2004; 27
Leech (10.4158/CS-2019-0472_bb1040) 2010; 2
(10.4158/CS-2019-0472_bb0955) 2017
Kahn (10.4158/CS-2019-0472_bb0015) 2003; 46
United Kingdom Hypoglycaemia Study Group (10.4158/CS-2019-0472_bb1435) 2007; 50
Sabatine (10.4158/C
References_xml – volume: 365
  start-page: 2255
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0825
  article-title: Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1107579
– volume: 23
  start-page: 487
  year: 2009
  ident: 10.4158/CS-2019-0472_bb1140
  article-title: Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin—diabetes control and potential adverse events
  publication-title: Best Pract Res Clin Endocrinol Metab
  doi: 10.1016/j.beem.2009.03.003
– volume: 12
  start-page: 384
  year: 2010
  ident: 10.4158/CS-2019-0472_bb1240
  article-title: Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
  publication-title: Diabetes Obes Metab
  doi: 10.1111/j.1463-1326.2009.01181.x
– volume: 52
  start-page: 2046
  year: 2009
  ident: 10.4158/CS-2019-0472_bb1380
  article-title: Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
  publication-title: Diabetologia
  doi: 10.1007/s00125-009-1472-y
– volume: 33
  start-page: 983
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0905
  article-title: Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial
  publication-title: Diabetes Care
  doi: 10.2337/dc09-1278
– volume: 298
  start-page: 1180
  year: 2007
  ident: 10.4158/CS-2019-0472_bb1175
  article-title: Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials
  publication-title: JAMA
  doi: 10.1001/jama.298.10.1180
– volume: 22
  start-page: 231
  year: 2016
  ident: 10.4158/CS-2019-0472_bb1470
  article-title: American Association of Clinical Endocrinologists and American College of Endocrinology 2016 outpatient glucose monitoring consensus statement
  publication-title: Endocr Pract
  doi: 10.4158/EP151124.CS
– volume: 172
  start-page: 1296
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0425
  article-title: Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2012.3147
– volume: 124
  start-page: 993
  year: 2011
  ident: 10.4158/CS-2019-0472_bb1460
  article-title: Death during intensive glycemic therapy of diabetes: mechanisms and implications
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2011.08.008
– volume: 21
  start-page: 1
  issue: suppl 1
  year: 2015
  ident: 10.4158/CS-2019-0472_bb0035
  article-title: American Association of Clinical Endocrinologists and American College of Endocrinology: clinical practice guidelines for developing a diabetes mellitus comprehensive care plan--2015
  publication-title: Endocr Pract
  doi: 10.4158/EP15672.GLSUPPL
– volume: 31
  start-page: 1305
  year: 2008
  ident: 10.4158/CS-2019-0472_bb0070
  article-title: Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine
  publication-title: Diabetes Care
  doi: 10.2337/dc07-2137
– volume: 358
  start-page: 2545
  year: 2008
  ident: 10.4158/CS-2019-0472_bb0900
  article-title: Effects of intensive glucose lowering in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0802743
– volume: 373
  start-page: 232
  year: 2015
  ident: 10.4158/CS-2019-0472_bb1155
  article-title: Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1501352
– volume: 360
  start-page: 7
  year: 2002
  ident: 10.4158/CS-2019-0472_bb0560
  article-title: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)09327-3
– volume: 22
  start-page: 753
  year: 2016
  ident: 10.4158/CS-2019-0472_bb1120
  article-title: American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis
  publication-title: Endocr Pract
  doi: 10.4158/EP161292.PS
– volume: 351
  start-page: 1755
  year: 1998
  ident: 10.4158/CS-2019-0472_bb0500
  article-title: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)04311-6
– volume: 377
  start-page: 1341
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0310
  article-title: Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)60205-5
– volume: 59
  start-page: 253
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0990
  article-title: Association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients
  publication-title: J Postgrad Med
  doi: 10.4103/0022-3859.123143
– volume: 28
  start-page: 254
  year: 2005
  ident: 10.4158/CS-2019-0472_bb1345
  article-title: Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/diacare.28.2.254
– volume: 31
  start-page: 811
  year: 2008
  ident: 10.4158/CS-2019-0472_bb0575
  article-title: Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
  publication-title: Diabetes Care
  doi: 10.2337/dc08-9018
– volume: 8
  start-page: 1335
  year: 2014
  ident: 10.4158/CS-2019-0472_bb1100
  article-title: Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
  publication-title: Drug Des Devel Ther
  doi: 10.2147/DDDT.S50773
– volume: 8
  start-page: 399
  year: 2000
  ident: 10.4158/CS-2019-0472_bb0085
  article-title: Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results
  publication-title: Obes Res
  doi: 10.1038/oby.2000.48
– volume: 165
  start-page: 936
  year: 2005
  ident: 10.4158/CS-2019-0472_bb0510
  article-title: Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.165.8.936
– volume: 8
  start-page: 267
  year: 2010
  ident: 10.4158/CS-2019-0472_bb1350
  article-title: Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada
  publication-title: Appl Health Econ Health Policy
  doi: 10.2165/11535380-000000000-00000
– volume: 311
  start-page: 507
  year: 2014
  ident: 10.4158/CS-2019-0472_bb0490
  article-title: 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)
  publication-title: JAMA
  doi: 10.1001/jama.2013.284427
– volume: 258
  start-page: 94
  year: 2005
  ident: 10.4158/CS-2019-0472_bb0815
  article-title: Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.2005.01528.x
– volume: 389
  start-page: 1399
  year: 2017
  ident: 10.4158/CS-2019-0472_bb0375
  article-title: 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)30069-7
– volume: 376
  start-page: 1713
  year: 2017
  ident: 10.4158/CS-2019-0472_bb0740
  article-title: Evolocumab and clinical outcomes in patients with cardiovascular disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1615664
– volume: 14
  start-page: 933
  year: 2008
  ident: 10.4158/CS-2019-0472_bb0365
  article-title: Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists
  publication-title: Endocr Pract
  doi: 10.4158/EP.14.7.933
– volume: 10
  start-page: 1178
  year: 2008
  ident: 10.4158/CS-2019-0472_bb1415
  article-title: Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
  publication-title: Diabetes Obes Metab
  doi: 10.1111/j.1463-1326.2008.00967.x
– volume: 763
  start-page: 38
  issue: Pt A
  year: 2015
  ident: 10.4158/CS-2019-0472_bb0730
  article-title: PCSK9 inhibitors: Novel therapeutic agents for the treatment of hypercholesterolemia
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2015.03.099
– volume: 37
  start-page: 912
  year: 2014
  ident: 10.4158/CS-2019-0472_bb0300
  article-title: Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release
  publication-title: Diabetes Care
  doi: 10.2337/dc13-1518
– volume: 127
  start-page: 36
  year: 2014
  ident: 10.4158/CS-2019-0472_bb0880
  article-title: Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2013.09.018
– volume: 32
  start-page: 772
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0200
  article-title: Polysomnographic and health-related quality of life correlates of restless legs syndrome in the Sleep Heart Health Study
  publication-title: Sleep
  doi: 10.1093/sleep/32.6.772
– volume: 376
  start-page: 419
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0890
  article-title: Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60576-4
– volume: 121
  start-page: 1951
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0480
  article-title: Cardiovascular and overall mortality risk in relation to alcohol consumption in patients with cardiovascular disease
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.865840
– volume: 30
  start-page: 1374
  year: 2007
  ident: 10.4158/CS-2019-0472_bb0045
  article-title: Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial
  publication-title: Diabetes Care
  doi: 10.2337/dc07-0048
– volume: 14
  start-page: 762
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0995
  article-title: Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes—a review and meta analysis
  publication-title: Diabetes Obes Metab
  doi: 10.1111/j.1463-1326.2012.01603.x
– volume: 377
  start-page: 644
  year: 2017
  ident: 10.4158/CS-2019-0472_bb1060
  article-title: Canagliflozin and cardiovascular and renal events in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1611925
– volume: 106
  start-page: 247
  year: 2014
  ident: 10.4158/CS-2019-0472_bb1280
  article-title: An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2014.08.011
– volume: 23
  start-page: 888
  year: 2000
  ident: 10.4158/CS-2019-0472_bb0520
  article-title: Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/diacare.23.7.888
– volume: 59
  start-page: 198
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0770
  article-title: Efficacy of colesevelam on lowering glycemia and lipids
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/FJC.0b013e31823a109f
– volume: 206
  start-page: 535
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0850
  article-title: Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2009.03.029
– volume: 38
  start-page: 637
  year: 2015
  ident: 10.4158/CS-2019-0472_bb1315
  article-title: New insulin glargine 300 Units. mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units. mL-1
  publication-title: Diabetes Care
  doi: 10.2337/dc14-0006
– volume: 20
  start-page: 977
  year: 2014
  ident: 10.4158/CS-2019-0472_bb0230
  article-title: American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the 2014 advanced frame-work for a new diagnosis of obesity as a chronic disease
  publication-title: Endocr Pract
  doi: 10.4158/EP14280.PS
– volume: 363
  start-page: 692
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0805
  article-title: Combination lipid therapy in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc1006407
– volume: 373
  start-page: 11
  year: 2015
  ident: 10.4158/CS-2019-0472_bb0355
  article-title: A randomized, controlled trial of 3.0 mg of liraglutide in weight management
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1411892
– volume: 370
  start-page: 1809
  year: 2014
  ident: 10.4158/CS-2019-0472_bb0705
  article-title: A 52-week placebo-controlled trial of evolocumab in hyperlipidemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1316222
– volume: 5
  start-page: 357
  year: 2012
  ident: 10.4158/CS-2019-0472_bb1220
  article-title: Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
  publication-title: Diabetes Metab Syndr Obes
  doi: 10.2147/DMSO.S28340
– year: 2017
  ident: 10.4158/CS-2019-0472_bb1010
– volume: 34
  start-page: S244
  issue: suppl 2
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0760
  article-title: Role of bile acid sequestrants in the treatment of type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc11-s237
– volume: 80
  start-page: 1461
  year: 2004
  ident: 10.4158/CS-2019-0472_bb0270
  article-title: Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/80.6.1461
– volume: 36
  start-page: 843
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0345
  article-title: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
  publication-title: Int J Obes (Lond)
  doi: 10.1038/ijo.2011.158
– volume: 394
  start-page: 121
  year: 2019
  ident: 10.4158/CS-2019-0472_bb1020
  article-title: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(19)31149-3
– volume: 334
  start-page: 574
  year: 1996
  ident: 10.4158/CS-2019-0472_bb0940
  article-title: Metformin
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199602293340906
– volume: 38
  start-page: 1687
  year: 2015
  ident: 10.4158/CS-2019-0472_bb1095
  article-title: Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition
  publication-title: Diabetes Care
  doi: 10.2337/dc15-0843
– volume: 380
  start-page: 347
  year: 2019
  ident: 10.4158/CS-2019-0472_bb1065
  article-title: Dapagliflozin and cardiovascular outcomes in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1812389
– volume: 33
  start-page: 1503
  year: 2010
  ident: 10.4158/CS-2019-0472_bb1250
  article-title: Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes
  publication-title: Diabetes Care
  doi: 10.2337/dc09-2009
– volume: 363
  start-page: 233
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0895
  article-title: Effects of medical therapies on retinopathy progression in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1001288
– volume: 372
  start-page: 1489
  year: 2015
  ident: 10.4158/CS-2019-0472_bb0710
  article-title: Efficacy and safety of alirocumab in reducing lipids and cardiovascular events
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1501031
– volume: 372
  start-page: 2387
  year: 2015
  ident: 10.4158/CS-2019-0472_bb0555
  article-title: Ezetimibe added to statin therapy after acute coronary syndromes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1410489
– volume: 7
  start-page: 771
  year: 2013
  ident: 10.4158/CS-2019-0472_bb1405
  article-title: Common standards of basal insulin titration in type 2 diabetes
  publication-title: J Diabetes Sci Technol
  doi: 10.1177/193229681300700323
– volume: 29
  start-page: 1220
  year: 2006
  ident: 10.4158/CS-2019-0472_bb0680
  article-title: Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study
  publication-title: Diabetes Care
  doi: 10.2337/dc05-2465
– volume: 11
  start-page: 1193
  year: 2015
  ident: 10.4158/CS-2019-0472_bb1305
  article-title: Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine
  publication-title: Expert Opin Drug Metab Toxicol
  doi: 10.1517/17425255.2015.1058779
– volume: 101
  start-page: 671
  year: 2001
  ident: 10.4158/CS-2019-0472_bb0615
  article-title: The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
  publication-title: Clin Sci (Lond)
  doi: 10.1042/cs1010671
– volume: 35
  start-page: 1446
  year: 2012
  ident: 10.4158/CS-2019-0472_bb1260
  article-title: Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets
  publication-title: Diabetes Care
  doi: 10.2337/dc11-1928
– volume: 363
  start-page: 245
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0280
  article-title: Multicenter, placebo-controlled trial of lorcaserin for weight management
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0909809
– volume: 359
  start-page: 995
  year: 2002
  ident: 10.4158/CS-2019-0472_bb0505
  article-title: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)08089-3
– volume: 33
  start-page: 1267
  year: 2016
  ident: 10.4158/CS-2019-0472_bb1395
  article-title: Making insulin accessible: does inhaled insulin fill an unmet need?
  publication-title: Adv Ther
  doi: 10.1007/s12325-016-0370-1
– volume: 18
  start-page: 642
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0235
  article-title: American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine
  publication-title: Endocr Pract
  doi: 10.4158/EP12160.PS
– volume: 109
  start-page: 706
  year: 2004
  ident: 10.4158/CS-2019-0472_bb0255
  article-title: Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000115514.44135.A8
– volume: 33
  start-page: 2692
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0160
  article-title: Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary
  publication-title: Diabetes Care
  doi: 10.2337/dc10-1548
– volume: 21
  start-page: 935
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0320
  article-title: A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
  publication-title: Obesity (Silver Spring)
  doi: 10.1002/oby.20309
– volume: 15
  start-page: 253
  year: 2007
  ident: 10.4158/CS-2019-0472_bb0185
  article-title: Short sleep duration is associated with reduced leptin levels and increased adiposity: results from the Quebec family study
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2007.512
– volume: 359
  start-page: 2417
  year: 2008
  ident: 10.4158/CS-2019-0472_bb0525
  article-title: Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0806182
– volume: 56
  start-page: 529
  year: 1988
  ident: 10.4158/CS-2019-0472_bb0105
  article-title: Effects of four maintenance programs on the long-term management of obesity
  publication-title: J Consult Clin Psychol
  doi: 10.1037/0022-006X.56.4.529
– volume: 25
  start-page: 10
  year: 2004
  ident: 10.4158/CS-2019-0472_bb1225
  article-title: Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies
  publication-title: Eur Heart J
  doi: 10.1016/S0195-668X(03)00468-8
– volume: 372
  start-page: 1500
  year: 2015
  ident: 10.4158/CS-2019-0472_bb0715
  article-title: Efficacy and safety of evolocumab in reducing lipids and cardiovascular events
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1500858
– volume: 362
  start-page: 774
  year: 2010
  ident: 10.4158/CS-2019-0472_bb1050
  article-title: Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy
  publication-title: N Engl J Med
  doi: 10.1056/NEJMp1001578
– volume: 94
  start-page: 20
  year: 2004
  ident: 10.4158/CS-2019-0472_bb0585
  article-title: Framingham risk score and prediction of lifetime risk for coronary heart disease
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2004.03.023
– volume: 358
  start-page: 2560
  year: 2008
  ident: 10.4158/CS-2019-0472_bb0885
  article-title: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0802987
– volume: 200
  start-page: 135
  year: 2008
  ident: 10.4158/CS-2019-0472_bb0855
  article-title: Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2008.06.003
– volume: 375
  start-page: 1834
  year: 2016
  ident: 10.4158/CS-2019-0472_bb1015
  article-title: Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1607141
– volume: 52
  start-page: 1695
  year: 2014
  ident: 10.4158/CS-2019-0472_bb0720
  article-title: Recent advances in physiological lipoprotein metabolism
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2013-0358
– volume: 362
  start-page: 1563
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0785
  article-title: Effects of combination lipid therapy in type 2 diabetes mellitus
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1001282
– volume: 344
  start-page: 3
  year: 2001
  ident: 10.4158/CS-2019-0472_bb0465
  article-title: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200101043440101
– volume: 369
  start-page: 1317
  year: 2013
  ident: 10.4158/CS-2019-0472_bb1150
  article-title: Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1307684
– volume: 35
  start-page: 2464
  year: 2012
  ident: 10.4158/CS-2019-0472_bb1340
  article-title: Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long)
  publication-title: Diabetes Care
  doi: 10.2337/dc12-1205
– volume: 32
  start-page: 1484
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0170
  article-title: Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehr007
– volume: 366
  start-page: 1640
  year: 2005
  ident: 10.4158/CS-2019-0472_bb0260
  article-title: Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67663-5
– volume: 125
  start-page: 1695
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0250
  article-title: Medical therapy for the patient with obesity
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.026567
– volume: 26
  start-page: 1047
  year: 2010
  ident: 10.4158/CS-2019-0472_bb1425
  article-title: Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007991003634759
– volume: 160
  start-page: 2150
  year: 2000
  ident: 10.4158/CS-2019-0472_bb0110
  article-title: A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.160.14.2150
– volume: 297
  start-page: 611
  year: 2007
  ident: 10.4158/CS-2019-0472_bb0595
  article-title: Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score
  publication-title: JAMA
  doi: 10.1001/jama.297.6.611
– volume: 52
  start-page: 1789
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0130
  article-title: Continuous low-to moderate-intensity exercise training is as effective as moderate-to high-intensity exercise training at lowering blood HbA(1c) in obese type 2 diabetes patients
  publication-title: Diabetologia
  doi: 10.1007/s00125-009-1354-3
– volume: 340
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0935
  article-title: The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
  publication-title: BMJ
  doi: 10.1136/bmj.b4909
– volume: 346
  start-page: 393
  year: 2002
  ident: 10.4158/CS-2019-0472_bb0370
  article-title: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa012512
– volume: 13
  start-page: 1020
  year: 2011
  ident: 10.4158/CS-2019-0472_bb1410
  article-title: Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month ‘proof-of-concept’ study
  publication-title: Diabetes Obes Metab
  doi: 10.1111/j.1463-1326.2011.01459.x
– volume: 375
  start-page: 311
  year: 2016
  ident: 10.4158/CS-2019-0472_bb1005
  article-title: Liraglutide and cardiovascular outcomes in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1603827
– volume: 28
  start-page: 888
  year: 2005
  ident: 10.4158/CS-2019-0472_bb0050
  article-title: Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program
  publication-title: Diabetes Care
  doi: 10.2337/diacare.28.4.888
– volume: 368
  start-page: 1800
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0860
  article-title: n-3 fatty acids in patients with multiple cardiovascular risk factors
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1205409
– volume: 33
  start-page: 1578
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0910
  article-title: Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
  publication-title: Diabetes Care
  doi: 10.2337/dc10-0125
– volume: 34
  start-page: 789
  year: 2011
  ident: 10.4158/CS-2019-0472_bb1245
  article-title: Bromocriptine: a sympatholytic, D2-dopamine agonist for the treatment of type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc11-0064
– volume: 24
  start-page: 1069
  year: 2001
  ident: 10.4158/CS-2019-0472_bb0210
  article-title: The prevalence of comorbid depression in adults with diabetes: a meta-analysis
  publication-title: Diabetes Care
  doi: 10.2337/diacare.24.6.1069
– volume: 39
  start-page: 689
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0700
  article-title: Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia
  publication-title: Eur J Clin Invest
  doi: 10.1111/j.1365-2362.2009.02163.x
– volume: 2
  start-page: 36
  year: 2008
  ident: 10.4158/CS-2019-0472_bb0690
  article-title: Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice
  publication-title: J Clin Lipidol
  doi: 10.1016/j.jacl.2007.12.006
– volume: 31
  start-page: 845
  year: 2008
  ident: 10.4158/CS-2019-0472_bb1195
  article-title: Rosiglitazone-associated fractures in type 2 diabetes: an analysis from A Diabetes Outcome Progression Trial (ADOPT)
  publication-title: Diabetes Care
  doi: 10.2337/dc07-2270
– volume: 376
  start-page: 595
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0335
  article-title: Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60888-4
– volume: 113
  start-page: 2363
  year: 2006
  ident: 10.4158/CS-2019-0472_bb0610
  article-title: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.174516
– volume: 64
  start-page: 485
  year: 2014
  ident: 10.4158/CS-2019-0472_bb0550
  article-title: Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2014.02.615
– volume: 373
  start-page: 2247
  year: 2015
  ident: 10.4158/CS-2019-0472_bb1030
  article-title: Lixisenatide in patients with type 2 diabetes and acute coronary syndrome
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1509225
– volume: 380
  start-page: 2295
  year: 2019
  ident: 10.4158/CS-2019-0472_bb1080
  article-title: Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1811744
– volume: 381
  start-page: 1995
  year: 2019
  ident: 10.4158/CS-2019-0472_bb1085
  article-title: Dapagliflozin in patients with heart failure and reduced ejection fraction
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1911303
– volume: 123
  start-page: 2799
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0420
  article-title: Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and Bayesian random-effects meta-analyses of randomized trials
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.016337
– volume: 366
  start-page: 1279
  year: 2005
  ident: 10.4158/CS-2019-0472_bb0410
  article-title: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67528-9
– volume: 372
  start-page: 1174
  year: 2008
  ident: 10.4158/CS-2019-0472_bb0515
  article-title: Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)61242-8
– volume: 3
  start-page: 364
  year: 2014
  ident: 10.4158/CS-2019-0472_bb0055
  article-title: Prevention of diabetes through the lifestyle intervention: lessons learned from the Diabetes Prevention Program and Outcomes Study and its translation to practice
  publication-title: Curr Nutr Rep
  doi: 10.1007/s13668-014-0094-2
– volume: 2012
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0075
  article-title: Meal replacements for weight loss in type 2 diabetes in a community setting
  publication-title: J Nutr Metab
  doi: 10.1155/2012/918571
– volume: 163
  start-page: 205
  year: 2003
  ident: 10.4158/CS-2019-0472_bb0190
  article-title: A prospective study of sleep duration and coronary heart disease in women
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.163.2.205
– volume: 204
  start-page: 342
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0765
  article-title: Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2008.09.026
– volume: 27
  start-page: 1360
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0430
  article-title: Prognostic value of blood pressure in patients with high vascular risk in the ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial study
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e32832d7370
– volume: 217
  start-page: 492
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0810
  article-title: Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2011.04.020
– volume: 373
  start-page: 2117
  year: 2015
  ident: 10.4158/CS-2019-0472_bb1055
  article-title: Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1504720
– volume: 81
  start-page: 184
  year: 2008
  ident: 10.4158/CS-2019-0472_bb1290
  article-title: Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2008.04.007
– volume: 379
  start-page: 1498
  year: 2012
  ident: 10.4158/CS-2019-0472_bb1325
  article-title: Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)60205-0
– volume: 352
  start-page: 174
  year: 2005
  ident: 10.4158/CS-2019-0472_bb1390
  article-title: Insulin analogues
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra040832
– volume: 69
  start-page: 198
  year: 1999
  ident: 10.4158/CS-2019-0472_bb0080
  article-title: Metabolic and weight-loss effects of a long-term dietary intervention in obese patients
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/69.2.198
– volume: 368
  start-page: 1096
  year: 2006
  ident: 10.4158/CS-2019-0472_bb0395
  article-title: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial [Erratum in: Lancet. 2006:368:1770]
  publication-title: Lancet
  doi: 10.1016/S0140-6736(06)69420-8
– volume: 8
  start-page: 61
  year: 2016
  ident: 10.4158/CS-2019-0472_bb1045
  article-title: The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
  publication-title: Clin Pharmacol
– volume: 37
  start-page: 1815
  year: 2014
  ident: 10.4158/CS-2019-0472_bb1365
  article-title: Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc13-3055
– volume: 159
  start-page: 1893
  year: 1999
  ident: 10.4158/CS-2019-0472_bb0755
  article-title: Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.159.16.1893
– volume: 36
  start-page: 858
  year: 2013
  ident: 10.4158/CS-2019-0472_bb1335
  publication-title: Diabetes Care
  doi: 10.2337/dc12-1668
– volume: 36
  start-page: 3821
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0065
  article-title: Nutrition therapy recommendations for the management of adults with diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc13-2042
– volume: 5
  start-page: 225
  year: 2013
  ident: 10.4158/CS-2019-0472_bb1090
  article-title: Sodium glucose transporter 2 inhibition: a new approach to diabetes treatment
  publication-title: J Diabetes
  doi: 10.1111/1753-0407.12065
– volume: 29
  start-page: 1478
  year: 2006
  ident: 10.4158/CS-2019-0472_bb0650
  article-title: Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)
  publication-title: Diabetes Care
  doi: 10.2337/dc05-2415
– volume: 170
  start-page: 1794
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0150
  article-title: Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES)
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2010.380
– year: 2018
  ident: 10.4158/CS-2019-0472_bb1075
– volume: 95
  start-page: 254
  year: 2005
  ident: 10.4158/CS-2019-0472_bb0840
  article-title: Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project)
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2004.09.013
– volume: 154
  start-page: 103
  year: 2011
  ident: 10.4158/CS-2019-0472_bb1375
  article-title: Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-154-2-201101180-00300
– volume: 369
  start-page: 1892
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0535
  article-title: Combined angiotensin inhibition for the treatment of diabetic nephropathy
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1303154
– volume: 12
  start-page: 131
  year: 2019
  ident: 10.4158/CS-2019-0472_bb0225
  article-title: The ABCD of obesity: an EASO position statement on a diagnostic term with clinical and scientific implications
  publication-title: Obes Facts
  doi: 10.1159/000497124
– volume: 376
  start-page: 1670
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0655
  article-title: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)61350-5
– volume: 19
  start-page: S3
  year: 2017
  ident: 10.4158/CS-2019-0472_bb1465
  article-title: Continuous glucose monitoring with multiple daily insulin treatment: outcome studies
  publication-title: Diabetes Technol Ther
  doi: 10.1089/dia.2017.0090
– volume: 364
  start-page: 1104
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0405
  article-title: Pioglitazone for diabetes prevention in impaired glucose tolerance
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1010949
– volume: 377
  start-page: 723
  year: 2017
  ident: 10.4158/CS-2019-0472_bb1300
  article-title: Efficacy and safety of degludec versus glargine in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1615692
– volume: 362
  start-page: 1575
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0435
  article-title: Effects of intensive blood-pressure control in type 2 diabetes mellitus
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1001286
– volume: 46
  start-page: 3
  year: 2003
  ident: 10.4158/CS-2019-0472_bb0015
  article-title: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
  publication-title: Diabetologia
  doi: 10.1007/s00125-002-1009-0
– volume: 64
  start-page: 172
  year: 1996
  ident: 10.4158/CS-2019-0472_bb0100
  article-title: An evaluation of a television-delivered behavioral weight loss program: are the ratings acceptable?
  publication-title: J Consult Clin Psychol
  doi: 10.1037/0022-006X.64.1.172
– volume: 169
  start-page: 851
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0455
  article-title: Consistency with the DASH diet and incidence of heart failure
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2009.56
– volume: 4
  start-page: 255
  year: 2002
  ident: 10.4158/CS-2019-0472_bb0820
  article-title: Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes
  publication-title: Diabetes Obes Metab
  doi: 10.1046/j.1463-1326.2002.00205.x
– volume: 355
  start-page: 2427
  year: 2006
  ident: 10.4158/CS-2019-0472_bb0945
  article-title: Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa066224
– volume: 30
  start-page: 1026
  year: 2013
  ident: 10.4158/CS-2019-0472_bb1205
  article-title: Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies
  publication-title: Diabet Med
  doi: 10.1111/dme.12144
– volume: 361
  start-page: 1149
  year: 2003
  ident: 10.4158/CS-2019-0472_bb0600
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)12948-0
– volume: 359
  start-page: 2072
  year: 2002
  ident: 10.4158/CS-2019-0472_bb0385
  article-title: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)08905-5
– volume: 341
  start-page: 410
  year: 1999
  ident: 10.4158/CS-2019-0472_bb0780
  article-title: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199908053410604
– volume: 42
  start-page: 219
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0125
  article-title: Low-intensity exercise reduces the prevalence of hyperglycemia in type 2 diabetes
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/MSS.0b013e3181b3b16d
– volume: 364
  start-page: 818
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0930
  article-title: Long-term effects of intensive glucose lowering on cardiovascular outcomes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1006524
– volume: 292
  start-page: 1307
  year: 2004
  ident: 10.4158/CS-2019-0472_bb0675
  article-title: Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial
  publication-title: JAMA
  doi: 10.1001/jama.292.11.1307
– volume: 38
  start-page: 1680
  year: 2015
  ident: 10.4158/CS-2019-0472_bb1115
  article-title: Diabetic ketoacidosis and related events in the canagliflozin type 2 diabetes clinical program
  publication-title: Diabetes Care
  doi: 10.2337/dc15-1251
– ident: 10.4158/CS-2019-0472_bb0750
– volume: 147
  start-page: 386
  year: 2007
  ident: 10.4158/CS-2019-0472_bb1190
  article-title: Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus [Erratum in Ann Intern Med. 2007;147:887]
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-147-6-200709180-00178
– volume: 3
  start-page: 1
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0965
  article-title: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease
  publication-title: Kidney Int Suppl
– volume: 380
  start-page: 11
  year: 2019
  ident: 10.4158/CS-2019-0472_bb0870
  article-title: Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1812792
– volume: 373
  start-page: 2125
  year: 2009
  ident: 10.4158/CS-2019-0472_bb1180
  article-title: Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)60953-3
– volume: 32
  start-page: 235
  year: 2002
  ident: 10.4158/CS-2019-0472_bb0215
  article-title: Anxiety and poor glycemic control: a meta-analytic review of the literature
  publication-title: Int J Psychiatry Med
  doi: 10.2190/KLGD-4H8D-4RYL-TWQ8
– volume: 37
  start-page: 3309
  year: 2014
  ident: 10.4158/CS-2019-0472_bb0315
  article-title: Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended-release
  publication-title: Diabetes Care
  doi: 10.2337/dc14-0930
– year: 2019
  ident: 10.4158/CS-2019-0472_bb1125
– volume: 41
  start-page: 119
  year: 2012
  ident: 10.4158/CS-2019-0472_bb1420
  article-title: Insulin therapy in type 2 diabetes mellitus
  publication-title: Endocrinol Metab Clin North Am
  doi: 10.1016/j.ecl.2012.03.004
– volume: 96
  start-page: 3067
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0290
  article-title: A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-1256
– volume: 37
  start-page: 2755
  year: 2014
  ident: 10.4158/CS-2019-0472_bb1320
  article-title: New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1)
  publication-title: Diabetes Care
  doi: 10.2337/dc14-0991
– volume: 33
  start-page: 926
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0220
  article-title: Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes: a systematic review and meta-analysis
  publication-title: Diabetes Care
  doi: 10.2337/dc09-1519
– volume: 22
  start-page: 1
  issue: suppl 3
  year: 2016
  ident: 10.4158/CS-2019-0472_bb0240
  article-title: American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity
  publication-title: Endocr Pract
  doi: 10.4158/EP161365.GL
– volume: 34
  start-page: 1431
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0970
  article-title: Use of metformin in the setting of mild-to-moderate renal insufficiency
  publication-title: Diabetes Care
  doi: 10.2337/dc10-2361
– volume: 27
  start-page: 492
  year: 2013
  ident: 10.4158/CS-2019-0472_bb1265
  article-title: One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target
  publication-title: J Diabetes Complications
  doi: 10.1016/j.jdiacomp.2013.04.008
– volume: 164
  start-page: 2031
  year: 2001
  ident: 10.4158/CS-2019-0472_bb0195
  article-title: Role of snoring and daytime sleepiness in occupational accidents
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.164.11.2102028
– volume: 28
  start-page: 513
  year: 2012
  ident: 10.4158/CS-2019-0472_bb1370
  article-title: Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007995.2012.665046
– volume: 19
  start-page: 1
  issue: suppl 3
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0115
  publication-title: Endocr Pract
  doi: 10.4158/EP13155.GL
– volume: 372
  start-page: 2197
  year: 2015
  ident: 10.4158/CS-2019-0472_bb0925
  article-title: Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1414266
– volume: 135
  start-page: 1019
  year: 2001
  ident: 10.4158/CS-2019-0472_bb0470
  article-title: Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-135-12-200112180-00005
– volume: 102
  start-page: 914
  year: 2017
  ident: 10.4158/CS-2019-0472_bb1210
  article-title: Pioglitazone and risk for bone fracture: safety data from a randomized clinical trial
  publication-title: J Clin Endocrinol Metab
– volume: 15
  start-page: 1307
  year: 2004
  ident: 10.4158/CS-2019-0472_bb0625
  article-title: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000123691.46138.E2
– volume: 289
  start-page: 2254
  year: 2003
  ident: 10.4158/CS-2019-0472_bb1440
  article-title: Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review
  publication-title: JAMA
  doi: 10.1001/jama.289.17.2254
– volume: 27
  start-page: 155
  year: 2004
  ident: 10.4158/CS-2019-0472_bb0275
  article-title: XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients [Erratum in Diabetes Care. 2004;27:856]
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.1.155
– volume: 19
  start-page: 337
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0360
  publication-title: Endocr Pract
  doi: 10.4158/EP12437.GL
– volume: 371
  start-page: 203
  year: 2014
  ident: 10.4158/CS-2019-0472_bb0830
  article-title: Effects of extended-release niacin with laropiprant in high-risk patients
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1300955
– volume: 60
  start-page: 1057
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0980
  article-title: Relationship between vitamin B12 and sensory and motor peripheral nerve function in older adults
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2012.03998.x
– volume: 19
  start-page: 526
  year: 2013
  ident: 10.4158/CS-2019-0472_bb1445
  article-title: Hypoglycemia: minimizing its impact in type 2 diabetes
  publication-title: Endocr Pract
  doi: 10.4158/EP13005.RA
– volume: 31
  start-page: 89
  year: 2015
  ident: 10.4158/CS-2019-0472_bb0155
  article-title: Falls risk in older adults with type 2 diabetes
  publication-title: Clin Geriatr Med
  doi: 10.1016/j.cger.2014.09.002
– volume: 25
  start-page: 330
  year: 2002
  ident: 10.4158/CS-2019-0472_bb1430
  article-title: Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57)
  publication-title: Diabetes Care
  doi: 10.2337/diacare.25.2.330
– volume: 28
  start-page: 950
  year: 2005
  ident: 10.4158/CS-2019-0472_bb1285
  article-title: Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/diacare.28.4.950
– volume: 66
  start-page: 1643
  year: 2015
  ident: 10.4158/CS-2019-0472_bb0590
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2015.08.035
– volume: 235
  start-page: 585
  year: 2014
  ident: 10.4158/CS-2019-0472_bb0635
  article-title: Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2014.05.914
– volume: 360
  start-page: 1623
  year: 2002
  ident: 10.4158/CS-2019-0472_bb0605
  article-title: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)11600-X
– volume: 30
  start-page: 2511
  year: 2007
  ident: 10.4158/CS-2019-0472_bb0140
  article-title: Exercise training improves glycemic control in long-standing insulin-treat-ed type 2 diabetic patients
  publication-title: Diabetes Care
  doi: 10.2337/dc07-0183
– volume: 25
  start-page: 729
  year: 2019
  ident: 10.4158/CS-2019-0472_bb0060
  article-title: Transcultural diabetes care in the United States—a position statement by the American Association of Clinical Endocrinologists
  publication-title: Endocr Pract
  doi: 10.4158/PS-2019-0080
– year: 2016
  ident: 10.4158/CS-2019-0472_bb0960
– volume: 95
  start-page: 4802
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0915
  article-title: The approach to the management of the patient with neuropathic pain
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-0892
– volume: 360
  start-page: 129
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0920
  article-title: Glucose control and vascular complications in veterans with type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0808431
– volume: 314
  start-page: 265
  year: 2015
  ident: 10.4158/CS-2019-0472_bb1215
  article-title: Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes
  publication-title: JAMA
  doi: 10.1001/jama.2015.7996
– volume: 20
  start-page: 330
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0305
  article-title: Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2011.330
– volume: 32
  start-page: 493
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0800
  article-title: Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1543
– volume: 9
  start-page: 999
  year: 2015
  ident: 10.4158/CS-2019-0472_bb1450
  article-title: Hypoglycemia in type 2 diabetes--more common than you think: a continuous glucose monitoring study
  publication-title: J Diabetes Sci Technol
  doi: 10.1177/1932296815581052
– volume: 392
  start-page: 1519
  year: 2018
  ident: 10.4158/CS-2019-0472_bb1025
  article-title: Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)32261-X
– volume: 58
  start-page: 773
  year: 2009
  ident: 10.4158/CS-2019-0472_bb1170
  article-title: From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus
  publication-title: Diabetes
  doi: 10.2337/db09-9028
– volume: 18
  start-page: 96
  year: 2016
  ident: 10.4158/CS-2019-0472_bb1310
  article-title: Comparison of insulin degludec with insulin detemir in type 1 diabetes: a 1-year treat-to-target trial
  publication-title: Diabetes Obes Metab
  doi: 10.1111/dom.12573
– volume: 33
  start-page: 156
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0985
  article-title: Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy
  publication-title: Diabetes Care
  doi: 10.2337/dc09-0606
– volume: 164
  start-page: 947
  year: 2006
  ident: 10.4158/CS-2019-0472_bb0175
  article-title: Association between reduced sleep and weight gain in women
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwj280
– volume: 100
  start-page: 3140
  year: 2015
  ident: 10.4158/CS-2019-0472_bb0735
  article-title: Alirocumab as add-on to atorvastatin versus other lipid treatment strategies: ODYSSEY OPTIONS I randomized trial
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2015-1520
– volume: 1
  year: 2012
  ident: 10.4158/CS-2019-0472_bb1255
  article-title: Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.112.002279
– volume: 29
  start-page: 1009
  year: 2006
  ident: 10.4158/CS-2019-0472_bb0180
  article-title: Association of usual sleep duration with hypertension: the Sleep Heart Health Study
  publication-title: Sleep
  doi: 10.1093/sleep/29.8.1009
– volume: 23
  start-page: 1
  issue: suppl 2
  year: 2017
  ident: 10.4158/CS-2019-0472_bb0630
  article-title: American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of atherosclerosis
  publication-title: Endocr Pract
  doi: 10.4158/EP171764.APPGL
– volume: 13
  start-page: 7
  year: 2011
  ident: 10.4158/CS-2019-0472_bb1135
  article-title: Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
  publication-title: Diabetes Obes Metab
  doi: 10.1111/j.1463-1326.2010.01306.x
– volume: 19
  start-page: 864
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0245
  article-title: New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach
  publication-title: Endocr Pract
  doi: 10.4158/EP13263.RA
– volume: 19
  start-page: 110
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0330
  article-title: Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2010.147
– volume: 364
  start-page: 685
  year: 2004
  ident: 10.4158/CS-2019-0472_bb0645
  article-title: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)16895-5
– volume: 106
  start-page: 3143
  year: 2002
  ident: 10.4158/CS-2019-0472_bb0545
  article-title: Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
  publication-title: Circulation
  doi: 10.1161/circ.106.25.3143
– volume: 2
  start-page: 72
  year: 2010
  ident: 10.4158/CS-2019-0472_bb1040
  article-title: Facilitation of ss-cell K(ATP) channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac
  publication-title: Islets
  doi: 10.4161/isl.2.2.10582
– volume: 60
  start-page: 1385
  year: 2017
  ident: 10.4158/CS-2019-0472_bb1105
  article-title: SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System
  publication-title: Diabetologia
  doi: 10.1007/s00125-017-4301-8
– volume: 19
  start-page: 403
  year: 2005
  ident: 10.4158/CS-2019-0472_bb0695
  article-title: Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients—the PRIMO study
  publication-title: Cardiovasc Drugs Ther
  doi: 10.1007/s10557-005-5686-z
– volume: 318
  start-page: 23
  year: 2017
  ident: 10.4158/CS-2019-0472_bb1400
  article-title: Human insulin for type 2 diabetes: an effective, less-expensive option
  publication-title: JAMA
  doi: 10.1001/jama.2017.6939
– volume: 48
  start-page: 438
  year: 2006
  ident: 10.4158/CS-2019-0472_bb0685
  article-title: Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2006.04.070
– volume: 137
  start-page: e67
  year: 2018
  ident: 10.4158/CS-2019-0472_bb0540
  article-title: Heart disease and stroke statistics—2018 update: a report from the American Heart Association
  publication-title: Circulation
  doi: 10.1161/CIR.0000000000000558
– volume: 157
  start-page: 601
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0950
  article-title: Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-157-9-201211060-00003
– year: 2017
  ident: 10.4158/CS-2019-0472_bb0955
– volume: 37
  start-page: 103
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0165
  article-title: Inadequate sleep as a contributor to obesity and type 2 diabetes
  publication-title: Can J Diabetes
  doi: 10.1016/j.jcjd.2013.02.060
– volume: 374
  start-page: 1677
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0390
  article-title: 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study [Erratum in Lancet. 2009;374:2054]
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)61457-4
– volume: 7
  start-page: 344
  year: 2019
  ident: 10.4158/CS-2019-0472_bb0265
  article-title: Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(19)30068-3
– volume: 21
  start-page: 522
  year: 2015
  ident: 10.4158/CS-2019-0472_bb1475
  article-title: Proceedings from the American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on glucose monitoring
  publication-title: Endocr Pract
  doi: 10.4158/EP15653.CS
– volume: 130
  start-page: 1579
  year: 2014
  ident: 10.4158/CS-2019-0472_bb1165
  article-title: Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.114.010389
– volume: 369
  start-page: 1327
  year: 2013
  ident: 10.4158/CS-2019-0472_bb1145
  article-title: Alogliptin after acute coronary syndrome in patients with type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1305889
– volume: 26
  start-page: 3080
  year: 2003
  ident: 10.4158/CS-2019-0472_bb1270
  article-title: The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
  publication-title: Diabetes Care
  doi: 10.2337/diacare.26.11.3080
– volume: 54
  start-page: 679
  year: 2003
  ident: 10.4158/CS-2019-0472_bb0665
  article-title: Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus
  publication-title: Angiology
  doi: 10.1177/000331970305400607
– volume: 363
  start-page: 1410
  year: 2010
  ident: 10.4158/CS-2019-0472_bb1455
  article-title: Severe hypoglycemia and risks of vascular events and death
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1003795
– volume: 10
  start-page: 302
  year: 2013
  ident: 10.4158/CS-2019-0472_bb1235
  article-title: Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies
  publication-title: Diab Vasc Dis Res
  doi: 10.1177/1479164112465442
– volume: 30
  start-page: e25
  year: 2007
  ident: 10.4158/CS-2019-0472_bb0120
  article-title: Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis: response to Snowling and Hopkins
  publication-title: Diabetes Care
  doi: 10.2337/dc06-2495
– volume: 36
  start-page: 2536
  year: 2013
  ident: 10.4158/CS-2019-0472_bb1330
  publication-title: Diabetes Care
  doi: 10.2337/dc12-2329
– volume: 327
  start-page: 1426
  year: 1992
  ident: 10.4158/CS-2019-0472_bb1355
  article-title: Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199211123272005
– volume: 37
  start-page: 1443
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0340
  article-title: Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study
  publication-title: Int J Obes (Lond)
  doi: 10.1038/ijo.2013.120
– volume: 38
  start-page: 613
  year: 2004
  ident: 10.4158/CS-2019-0472_bb0475
  article-title: A meta-analysis of alcohol consumption and the risk of 15 diseases
  publication-title: Prev Med
  doi: 10.1016/j.ypmed.2003.11.027
– volume: 13
  start-page: 123
  year: 2015
  ident: 10.4158/CS-2019-0472_bb0725
  article-title: Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
  publication-title: BMC Med
  doi: 10.1186/s12916-015-0358-8
– volume: 317
  start-page: 1237
  year: 1987
  ident: 10.4158/CS-2019-0472_bb0775
  article-title: Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198711123172001
– year: 2018
  ident: 10.4158/CS-2019-0472_bb1130
– volume: 52
  start-page: 102
  year: 2003
  ident: 10.4158/CS-2019-0472_bb0010
  article-title: Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/diabetes.52.1.102
– volume: 374
  start-page: 1321
  year: 2016
  ident: 10.4158/CS-2019-0472_bb0415
  article-title: Pioglitazone after ischemic stroke or transient ischemic attack
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1506930
– volume: 30
  start-page: 162
  year: 2007
  ident: 10.4158/CS-2019-0472_bb0450
  article-title: Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association
  publication-title: Diabetes Care
  doi: 10.2337/dc07-9917
– volume: 27
  start-page: 2323
  year: 2006
  ident: 10.4158/CS-2019-0472_bb0670
  article-title: Acute coronary syndromes and diabetes: is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehl220
– volume: 60
  start-page: 1552
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0020
  article-title: Effects of rosiglitazone, glyburide, and metformin on beta-cell function and insulin sensitivity in ADOPT
  publication-title: Diabetes
  doi: 10.2337/db10-1392
– volume: 50
  start-page: 1140
  year: 2007
  ident: 10.4158/CS-2019-0472_bb1435
  article-title: Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
  publication-title: Diabetologia
  doi: 10.1007/s00125-007-0599-y
– volume: 85
  start-page: 37
  year: 1992
  ident: 10.4158/CS-2019-0472_bb0790
  article-title: Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment
  publication-title: Circulation
  doi: 10.1161/01.CIR.85.1.37
– volume: 156
  start-page: 405
  year: 2012
  ident: 10.4158/CS-2019-0472_bb1360
  article-title: Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-156-6-201203200-00003
– volume: 17
  start-page: 713
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0040
  article-title: One-year weight losses in the Look AHEAD study: factors associated with success
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2008.637
– volume: 367
  start-page: 309
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0865
  article-title: n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1203859
– volume: 2
  start-page: 655
  year: 2014
  ident: 10.4158/CS-2019-0472_bb0875
  article-title: The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(13)70191-8
– volume: 67
  start-page: 260
  year: 1999
  ident: 10.4158/CS-2019-0472_bb0090
  article-title: Behavioral choice treatment promotes continuing weight loss: preliminary results of a cognitive-behavioral decision-based treatment for obesity
  publication-title: J Consult Clin Psychol
  doi: 10.1037/0022-006X.67.2.260
– volume: 8
  start-page: 262
  year: 2000
  ident: 10.4158/CS-2019-0472_bb0205
  article-title: Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients
  publication-title: Obes Res
  doi: 10.1038/oby.2000.31
– volume: 371
  start-page: 117
  year: 2008
  ident: 10.4158/CS-2019-0472_bb0660
  article-title: Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)60104-X
– year: 2018
  ident: 10.4158/CS-2019-0472_bb1070
– volume: 29
  start-page: 1269
  year: 2006
  ident: 10.4158/CS-2019-0472_bb1275
  article-title: A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc05-1365
– volume: 28
  start-page: 2823
  year: 2005
  ident: 10.4158/CS-2019-0472_bb0445
  article-title: Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome
  publication-title: Diabetes Care
  doi: 10.2337/diacare.28.12.2823
– volume: 36
  start-page: 4022
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0325
  article-title: Effects of naltrex-one sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in over-weight and obese patients with type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc13-0234
– volume: 23
  start-page: 97
  year: 1998
  ident: 10.4158/CS-2019-0472_bb0095
  article-title: Effects of a personalized system of skill acquisition and an educational program in the treatment of obesity
  publication-title: Addict Behav
  doi: 10.1016/S0306-4603(97)00016-6
– volume: 377
  start-page: 1228
  year: 2017
  ident: 10.4158/CS-2019-0472_bb1035
  article-title: Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1612917
– volume: 45
  start-page: 1644
  year: 2005
  ident: 10.4158/CS-2019-0472_bb0565
  article-title: Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2005.02.080
– volume: 54
  start-page: 1150
  year: 2005
  ident: 10.4158/CS-2019-0472_bb0400
  article-title: Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.4.1150
– volume: 37
  start-page: 225
  year: 2015
  ident: 10.4158/CS-2019-0472_bb1000
  article-title: Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2014.11.008
– volume: 20
  start-page: 1426
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0285
  article-title: Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2012.66
– volume: 23
  start-page: 372
  year: 2017
  ident: 10.4158/CS-2019-0472_bb0025
  article-title: Adiposity-based chronic disease as a new diagnostic term: the American Association of Clinical Endocrinologists and American College of Endocrinology position statement
  publication-title: Endocr Pract
  doi: 10.4158/EP161688.PS
– volume: 259
  start-page: 247
  year: 2006
  ident: 10.4158/CS-2019-0472_bb0570
  article-title: Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.2006.01616.x
– volume: 110
  start-page: 227
  year: 2004
  ident: 10.4158/CS-2019-0472_bb0580
  article-title: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000133317.49796.0E
– volume: 385
  start-page: 2067
  year: 2015
  ident: 10.4158/CS-2019-0472_bb1160
  article-title: Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)62225-X
– volume: 13
  start-page: 441
  year: 2017
  ident: 10.4158/CS-2019-0472_bb1110
  article-title: Diabetes: SGLT2 inhibitors and diabetic ketoacidosis—a growing concern
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2017.77
– ident: 10.4158/CS-2019-0472_bb0745
– volume: 32
  start-page: 1434
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0460
  article-title: Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: the Insulin Resistance Atherosclerosis Study
  publication-title: Diabetes Care
  doi: 10.2337/dc09-0228
– volume: 91
  start-page: 3349
  year: 2006
  ident: 10.4158/CS-2019-0472_bb1200
  article-title: Thiazolidinedione use and bone loss in older diabetic adults
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-2226
– volume: 5
  start-page: 105
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0640
  article-title: Clinical implications of discordance between low-density lipoprotein cholesterol and particle number
  publication-title: J Clin Lipidol
  doi: 10.1016/j.jacl.2011.02.001
– volume: 101
  start-page: 40S
  issue: 4A
  year: 1996
  ident: 10.4158/CS-2019-0472_bb0620
  article-title: Lipid management: current diet and drug treatment options
  publication-title: Am J Med
  doi: 10.1016/S0002-9343(96)00319-1
– volume: 277
  start-page: 1624
  year: 1997
  ident: 10.4158/CS-2019-0472_bb0440
  article-title: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials
  publication-title: JAMA
  doi: 10.1001/jama.1997.03540440058033
– volume: 35
  start-page: 327
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0975
  article-title: Association of biochemical B12 deficiency with metformin therapy and vitamin B12 supplements: the National Health and Nutrition Examination Survey, 1999–2006
  publication-title: Diabetes Care
  doi: 10.2337/dc11-1582
– volume: 57
  start-page: 267
  year: 2011
  ident: 10.4158/CS-2019-0472_bb0795
  article-title: Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: a systematic review and meta-analysis
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/FJC.0b013e318202709f
– volume: 369
  start-page: 1090
  year: 2007
  ident: 10.4158/CS-2019-0472_bb0845
  article-title: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)60527-3
– volume: 95
  start-page: 297
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0295
  article-title: Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.111.024927
– volume: 369
  start-page: 1285
  year: 2013
  ident: 10.4158/CS-2019-0472_bb1185
  article-title: The cardiovascular safety of diabetes drugs—insights from the rosiglitazone experience
  publication-title: N Engl J Med
  doi: 10.1056/NEJMp1309610
– volume: 355
  start-page: 253
  year: 2000
  ident: 10.4158/CS-2019-0472_bb0495
  article-title: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. [Erratum in Lancet. 2000;356:860]
  publication-title: Lancet
  doi: 10.1016/S0140-6736(99)12323-7
– volume: 38
  start-page: 2037
  year: 2006
  ident: 10.4158/CS-2019-0472_bb0135
  article-title: Influence of acute exercise on hyperglycemia in insulin-treated type 2 diabetes
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/01.mss.0000235352.09061.1d
– volume: 374
  start-page: 1606
  year: 2009
  ident: 10.4158/CS-2019-0472_bb0350
  article-title: Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)61375-1
– volume: 303
  start-page: 1410
  year: 2010
  ident: 10.4158/CS-2019-0472_bb1230
  article-title: Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes
  publication-title: JAMA
  doi: 10.1001/jama.2010.405
– volume: 24
  start-page: 995
  year: 2018
  ident: 10.4158/CS-2019-0472_bb0030
  article-title: Dysglycemia-based chronic disease: an American Association of Clinical Endocrinologists position statement
  publication-title: Endocr Pract
  doi: 10.4158/PS-2018-0139
– volume: 61
  start-page: 440
  year: 2013
  ident: 10.4158/CS-2019-0472_bb0835
  article-title: The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2012.10.030
– start-page: 285
  year: 2001
  ident: 10.4158/CS-2019-0472_bb0485
  article-title: Exercise and Hypertension. ACSM's Resource Manual for Guidelines for Exercise Testing and Prescription
– volume: 12
  start-page: 167
  year: 2010
  ident: 10.4158/CS-2019-0472_bb1385
  article-title: Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
  publication-title: Diabetes Obes Metab
  doi: 10.1111/j.1463-1326.2009.01173.x
– volume: 290
  start-page: 486
  year: 2003
  ident: 10.4158/CS-2019-0472_bb0380
  article-title: Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial
  publication-title: JAMA
  doi: 10.1001/jama.290.4.486
– volume: 367
  start-page: 2204
  year: 2012
  ident: 10.4158/CS-2019-0472_bb0530
  article-title: Cardiorenal end points in a trial of aliskiren for type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1208799
– volume: 304
  start-page: 2253
  year: 2010
  ident: 10.4158/CS-2019-0472_bb0145
  article-title: Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial [Erratum in JAMA. 2011;305:892]
  publication-title: JAMA
  doi: 10.1001/jama.2010.1710
– volume: 12
  start-page: 772
  year: 2010
  ident: 10.4158/CS-2019-0472_bb1295
  article-title: Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine
  publication-title: Diabetes Obes Metab
  doi: 10.1111/j.1463-1326.2010.01232.x
SSID ssj0020918
Score 2.6785986
SecondaryResourceType review_article
Snippet Abbreviations: A1C = hemoglobin A1C; AACE = American Association of Clinical Endocrinologists; ABCD = adiposity-based chronic disease; ACCORD = Action to...
SourceID unpaywall
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 107
SubjectTerms Algorithms
Blood Glucose
Blood Glucose Self-Monitoring
Carbohydrates
Chronic illnesses
Clinical medicine
Consensus
Counseling
Diabetes
Diabetes Mellitus, Type 2
Diabetic ketoacidosis
Endocrinologists
Endocrinology
Ethnicity
Fatty acids
FDA approval
Food
Glucose
Humans
Hypoglycemia
Insulin resistance
Intervention
Lifestyles
Lipids
Meals
Metabolism
Nutrition
Obesity
Patients
Prevention
Proprotein Convertase 9
United States
Weight control
SummonAdditionalLinks – databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ditQwFA46C8pe-O9aWeUI6o10p03TaXo5LLMswi7CODBelTZJd8XaDtMWHa98Bx_K9_BJPGfSzowMgnjdkzRtvpx8yflj7CWP_TTXUeRGSGZdkYnUTVEnupkJMyWkDqJ1noKLy9H5TLydh_Pthdvaq7LUlaLQtz5OyKYLtj9yOMUl6snYn3OyiY1G0XCh85vsYBQiFx-wg9nlu_EHmyTVc0nOmpUFmREC6_mOe5YcqhoBQgE8IuJ_7kl7RPOQ3W7LRbr6khbFzuZzdpclfQiP9Tn5dNI22Yn6tp_R8T-_6x670_FSGFu5--yGKR-wWxed5f0h-0mVPaksRg1rfkqXipCtAPkj9FYf2JlrqHLoco4WMOnGVNl4oxrSUm9bdXcX1GJXcAXYC3VPKmtprq2nPdDBGTh0njw1bP13YFxcVcuPzfVn-PX9B3CkqDD5alRLGh2mNkrvEZudTd6fnrtdEQhXIdNrXM1FaMwoRx6YG8NlqinnnfYy7QVZLBFmXur7eRBwqfAwlknfeDHxqjDPU6Xz4DEblFVpnjBQRHa1xE1bhEJjOxFKZL-B9k0cqDhy2JseBonqMqRToY4iwZMSgSY5nSYEmoRA47BXG-mFzQzyF7njHlFJpx_qhOMcSyq2EzvsxeYxrmwy16Slqdq1DB5fOX6Lw44sEjcvoqr3VFrAYa830Nwbhaq3o3j6r4LHbNAsW_MMqVaTPe_W02_zvioT
  priority: 102
  providerName: Unpaywall
Title Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary
URI https://www.ncbi.nlm.nih.gov/pubmed/32022600
https://www.proquest.com/docview/2350896189
https://www.proquest.com/docview/2351492065
http://www.endocrinepractice.org/article/S1530891X20350667/pdf
UnpaywallVersion publishedVersion
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1934-2403
  dateEnd: 20201231
  omitProxy: true
  ssIdentifier: ssj0020918
  issn: 1934-2403
  databaseCode: 7X7
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1934-2403
  dateEnd: 20201231
  omitProxy: true
  ssIdentifier: ssj0020918
  issn: 1934-2403
  databaseCode: BENPR
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JjtNAEC3NZCSWA2InMIwaCbgga-JtbB8QcpzOxCixo9gZOSfLdrdPURKYRIgb_8BH8R98CVVekkEjOPng3uyq7nq9vQfwVnPUrBSWpVgIZhUjNzIlwzFRyaWZF4YtdKviKZgEF6O58TkxkyMI2rswdKyyHROrgVqsC1ojP9d0hBIkT-J82nxRSDWKdldbCY2skVYQHyuKsWM40YgZqwMnfR5MZ_spGEZHu2ZQ7Sm2oyb1UXgMYva5F6HH0I0ew9L-DlK3kOd9uLtbbbLv37Ll8kY0Gj6EBw2MZG5t90dwJFeP4c6k2Sh_Ar-8MIh4EM0jFsVuXFH2s_6CxSPOWqFHVlE6-tUiFQuHzBv7AbEjMB4MQm_mB5VQQhRHzA0Gh1xeOB7zS045biZcMCyFivfCCZp1hJX7V5zFiylnGhv4bp_HPGIHBQHmji_DmR-PJuz3j59Mw9_GeMK9eUz5aLR3Z4unMB_y2BspjWaDUiAw2ypCM0wpL0qEbaWUmp0JoqgTvVz09Nyx0St6maqWuq7ZBc6dcluVPYdgkFmWWSFK_Rl0VuuVfAGsIGwqbIyxhmkIzGeYNoJVXajS0QvH6sKH1khp0RCak67GMsWJDZk09aKUTJqSSbvwbp96UxN5_CPdaWvvtOnO1-nB-brwZv8aOyLtrmQrud5VaXC2qeG3dOF57Sf7ikiknpQAuvB-7zi3WlFcH1rx8v-teAX3yCr1UtApdLZfd_I1gqNtfgbHVmKdNX6Pz3kwdRd_AOqZ_oY
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVqJwQLwJFFgkygVZjdfr2j5UyHE2taljV7FTJSdje9enyAkkUdUb_4H_w5X_wS9h1o-kqIJbz559eGd255t9zIfQe2KpacENQzEAzCo0o6mSwpqoZELPcmpyzajyFAyDY3dMP0_0yQ762b6Fkdcq2zWxWqj5PJd75EdEAygh6UmsT4uvimSNkqerLYVG2lAr8JMqxVjzsONMXF1CCLc88fqg70NCBix2XKVhGVBygBIrhROqC3FcANAohCBmymVSNd7NeFfLLBP-o5uqaqFpxMwB7WemKrqWdNx6UaQ5LzSo9w7aoxq1IPjb67HgfLQJ-cAbm3XG1q5iWuqkvnoPTtM8ciKwUPmCiBrkb6d4A-neR_vrcpFeXaaz2TXvN3iIHjSwFdu1nT1CO6J8jO4Om4P5J-iXEwYRC6JxhKPYjiuKANyb4thluCWWxFUKSa_aFMPhADu-F8gRwizoh87ICypihiiOsB30t6Wc0PfZKZMlrgtOMdQiq3fCIZiRC417FwzH03OGCe57do_FLMJbxgJs-6fhyIvdIf79_QcmMGyYTZgzjmU56V3s0fQpGt-K9p6h3XJeihcI5xILcxN8OtUph3JUNwEca1wVlpZbRgd9bJWU5E0CdcnjMUsgkJIqTZwokSpNpEo76HAjvagTh_xD7qDVd9IsH8tka-wd9G7zGSa-PM1JSzFfVzIQ3RL4lw56XtvJpiENxlAyD3TQh43h3OhFvtz24uX_e_EW7bvx0E_ALs5eoXtSQ_U21AHaXX1bi9cAzFbZm8b6Mfpy2xPuD4d4ORI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtNAFB2VIhVYIN4ECgwSZYOsxDN2bS8Qcp1JY5rYVe1UycrYnvEqSgJJVHXHP_A3_AD_wZdwrx9JUQW7rj0vzz0z98zrHkLeMUdPC2lZmgVkVjMyI9VSmBO1TJlZbtiSW2WcgmFw2B8Zn8fmeIf8bN7C4LXKZk4sJ2o5z3GPvM04UAmUJ3HaRX0t4rTb-7T4qqGCFJ60NnIaFURO1OUFLN-WH_0u2PqAsZ6Ivb5WKwxoOdCIlSaZYSp1WADJKJRidioxoJrsZLLDM8eGf-ikul5wzuwcmH5m66rjoNM2iyLNZcGh3FvktsW5g9cJrfF2sQd-2K5itXY029HH1aV7cJd224sAm_h2yLDY3-7wGse9R-6sZ4v08iKdTq_4vd4Dcr8mrNStEPaQ7KjZI7I3rI_kH5NfXhhEIohGEY1iNy7FAejRhMZ9QRtJSVoGj_TL7TAa9qg38APsHyqCbuid-UEpyRDFEXWD7jaXFw4G4lhgjqsJJxRKweK9cAgA6kPl_rmg8eRUUEa7vnskYhHRrVYBdQfH4Zkf94f09_cflEG3UTEW3ijGfOhX3LPJEzK6Eds9Jbuz-Uw9JzRHFixt8OaGaUjIZ5g20GIudeXw3LFa5ENjpCSvQ6ejgsc0gSUUmjTxogRNmqBJW-Rgk3pRhQz5R7r9xt5JPXEsky3MW-Tt5jMMeTzHSWdqvi7TwLqWwb-0yLMKJ5uKOPQhag60yPsNcK61Il9uW_Hi_614Q_ZgmCUAi5OX5C4aqNp_2ie7q29r9QoY2Sp7XUKfki83Pdb-AK3YNqw
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ditQwFA46C8pe-O9aWeUI6o10p03TaXo5LLMswi7CODBelTZJd8XaDtMWHa98Bx_K9_BJPGfSzowMgnjdkzRtvpx8yflj7CWP_TTXUeRGSGZdkYnUTVEnupkJMyWkDqJ1noKLy9H5TLydh_Pthdvaq7LUlaLQtz5OyKYLtj9yOMUl6snYn3OyiY1G0XCh85vsYBQiFx-wg9nlu_EHmyTVc0nOmpUFmREC6_mOe5YcqhoBQgE8IuJ_7kl7RPOQ3W7LRbr6khbFzuZzdpclfQiP9Tn5dNI22Yn6tp_R8T-_6x670_FSGFu5--yGKR-wWxed5f0h-0mVPaksRg1rfkqXipCtAPkj9FYf2JlrqHLoco4WMOnGVNl4oxrSUm9bdXcX1GJXcAXYC3VPKmtprq2nPdDBGTh0njw1bP13YFxcVcuPzfVn-PX9B3CkqDD5alRLGh2mNkrvEZudTd6fnrtdEQhXIdNrXM1FaMwoRx6YG8NlqinnnfYy7QVZLBFmXur7eRBwqfAwlknfeDHxqjDPU6Xz4DEblFVpnjBQRHa1xE1bhEJjOxFKZL-B9k0cqDhy2JseBonqMqRToY4iwZMSgSY5nSYEmoRA47BXG-mFzQzyF7njHlFJpx_qhOMcSyq2EzvsxeYxrmwy16Slqdq1DB5fOX6Lw44sEjcvoqr3VFrAYa830Nwbhaq3o3j6r4LHbNAsW_MMqVaTPe_W02_zvioT
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CONSENSUS+STATEMENT+BY+THE+AMERICAN+ASSOCIATION+OF+CLINICAL+ENDOCRINOLOGISTS+AND+AMERICAN+COLLEGE+OF+ENDOCRINOLOGY+ON+THE+COMPREHENSIVE+TYPE+2+DIABETES+MANAGEMENT+ALGORITHM+-+2020+EXECUTIVE+SUMMARY&rft.jtitle=Endocrine+practice&rft.au=Garber%2C+Alan+J&rft.au=Handelsman%2C+Yehuda&rft.au=Grunberger%2C+George&rft.au=Einhorn%2C+Daniel&rft.date=2020-01-01&rft.issn=1530-891X&rft.volume=26&rft.issue=1&rft.spage=107&rft_id=info:doi/10.4158%2FCS-2019-0472&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-891X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-891X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-891X&client=summon